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1 Introduction
Back pain recognizes no age, economic or ethnic barriers [1]. During the last
four  years,  doing research leading to this  thesis,  I  myself  was struck by back
pain once. It wore off after some weeks, but it really showed me how important
your back is in everyday life. Also it has encouraged me to do this research. It
was staggering how many people, as soon
as they heard about my research on back
pain, asked me for advice on their own
back pain or  on the back pain of  a  loved
one. The most prominent and telling
example is the e-mail (see Appendix 1 and
the quote on this page) which I received
from  a  man  in  Scotland,  after  he  found
and read on the internet, the article
described in Chapter 3. As I am not a physician, it grieved me not being able to
help the people who came to me for advice, to get rid of their debilitating back
pain.  However,  I  hope  this  work  will  be  continued  in  order  to  make  a
contribution  to  the  management  of  back  pain  and  to  provide  orthopaedic
surgeons with engineered polymeric biomaterials as viable alternatives in
combating back pain.
2 Epidemiology
Back  pain  is  a  considerable  health  problem in  all  developed  countries,  with  a
lifetime prevalence of about 70% and an average point prevalence of 30% [2-
4]. In effect, it is the largest cause of activity limitation in people younger than
45 years, a major cause of work absenteeism and one of the most frequent
reasons for visiting a physician or physical therapist [4-6]. It could be said that
back pain is a universal epidemic. The impact of back pain on society is usually
estimated  by  examining  the  costs.  In  the  Netherlands  in  2000,  the  direct
medical costs of back pain were estimated to be 337.3 million euros, 0.9% of
the total medical costs [3]. However, the indirect costs, e.g. production losses
due to work absenteeism and disablement, are much higher and were
estimated  in  1991  to  consist  of  93%  of  the  total  costs  of  back  pain  [5].
Assuming an equal ratio in 2000, this would mean a total cost of back pain of
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4.8 billion euros,  which corresponds to  1.1% of  the gross  national  product  in
that year [7]. Moreover, the ageing of the population will result in a strong
increase in the amount of ailments to the locomotor apparatus, of which the
back is an important participant. Because of the large impact of these ailments
on society, the growing severity of the situation is recognized internationally
and the years 2000-2010 are proclaimed as The Bone and Joint Decade [8].
One  of  the  primary  goals  is  to  raise  awareness  of  the  growing  burden  of
musculo-skeletal  disorders  on  society.  As  a  part  of  this  initiative,  in  the
Netherlands the year 2007 is declared the year of back and neck pain. Besides
the  economic  impact,  back  pain  evidently  also  has  a  huge  psychological  and
social impact [4, 9]. The reverse is also true, i.e. social and psychological
aspects have an unmistakable influence on back pain [10].
In general, people experiencing acute back pain will see their pain and related
disability resolve in a few weeks time, but recurrences are common. The
severity of these recurrences is usually less and hence does not always lead to
a  new visit  to  the  physician.  Only  a  small  proportion  (5%)  of  people  with  an
acute  episode  of  back  pain  develop  chronic  back  pain  (pain  that  persists  for
over 3 months) [2]. In most cases, back pain occurs in the low back since this
part carries the most (body)weight and the largest moments [11].
From all the people suffering from back pain and who consult a physician, only
about 10% receive a specific diagnosis, like hernia nucleus pulposus (HNP, ±
5%)  among  others.  Non-specific  back  pain  is  defined  as  symptoms  with  no
clear  specific  cause,  which  is  the  case  in  the  other  90% of  people  with  back
pain  [2,  3].  In  the  Netherlands  44,600  people  with  acute  back  pain  were
diagnosed  with  HNP  in  the  year  2000.  It  is  a  common  misconception  that
radiographs and newer imaging techniques, like computed tomography (CT)
and magnetic  resonance imaging (MRI)  can always identify  the cause of  pain
[12].
Another ailment of the back, occurring more and more are vertebral
compression fractures [13, 14]. Especially postmenopausal women are
vulnerable  for  this  pathology,  affecting approximately  25% of  women over  50
years of age [15]. Osteoporosis lies at its base; it weakens the vertebral bodies
and these can fracture under (excessive) loading [16]. Osteoporosis is
associated with age and as a result vertebral compression fractures are
expected to become a growing problem due to the ageing of the population.
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3 The spinal motion segment
The human spine is designed around the spinal cord, which lies at its center.
The spine has at least three fundamental biomechanical functions: (i) it
transfers the weights and bending moments of the head and the trunk to the
pelvis, (ii) it allows sufficient physiological motion between these three body
parts and (iii) most importantly, it protects the spinal cord from potentially
damaging forces or motions produced by trauma [11].
Figure 1: The human spine and its regions, front and lateral view.
The spine consists of seven cervical vertebrae, twelve thoracic vertebrae, five
lumbar vertebrae, five fused sacral vertebrae and three to four fused coccygeal
vertebrae (Figure 1). The vertebrae are numbered from top to bottom: cervical
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C1-C7, thoracic T1-T12, lumbar L1-L5, sacral S1-S5 and coccygeal Co1-Co4.
Except for the upper two cervical vertebrae, i.e. the atlas and the axis, the
cervical, thoracic and lumbar vertebrae are separated by flexible intervertebral
discs. Because of their flexibility, the discs allow the spine to twist and bend so
that the body is able to assume a wide range of postures. It is often supposed
that  their  primary  function  is  to  act  as  shock  absorbers,  but  there  is
considerable  evidence  against  this  supposition:  (i)  the  disc  does  not  act  as  a
shock absorber during in vitro mechanical tests; (ii) shock absorption is
normally achieved by the musculature; (iii) there is no reason why the spine
needs  to  be  regularly  punctuated  by  shock  absorbers  any  more  than  do  the
other long bones. The discs act as joints, which are responsible for the essential
flexibility  of  the  spine  to  perform  its  function  as  the  main  component  of  the
axial  skeleton  [17].  Along  the  length  of  the  spine  there  are  also  various
ligaments that protect the spinal cord by restricting motions within well-defined
limits  [11].  A  spinal  part  consisting  of  two  adjacent  vertebrae  with  the
intervertebral disc in between is called a motion segment (Figure 2). The
motion segment has three joints; the intervertebral disc and two facet joints.
Figure 2: The spinal motion segment consisting of two adjacent vertebrae and
the intervertebral disc in between.
3.1 The vertebra
The human vertebrae increase in size from C1 to L5, as a mechanical
adaptation to the progressively increasing loads to which they are subjected.
The basic structure however is the same; it consists of an anterior block of
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bone, the vertebral body, and a posterior bony ring, the neural arch (Figure 3).
This arch contains articular (facet joints), transverse and spinous processes.
The spinal cord runs through the neural arches of the vertebrae. The vertebral
body is a roughly cylindrical mass of cancellous bone, surrounded by a thin shell
of cortical bone. Its superior and inferior surfaces are slightly concave and
accommodate the cartilaginous end-plates. Only the fused sacral and coccygeal
vertebrae are basically different [11].
Figure 3: Typical lumbar vertebra, top view (left) and lateral view (right). (VB -
vertebral body, NA - neural arch, AP - articular process, TP - transverse
process, SP – spinous process).
3.2 The intervertebral disc
The human intervertebral disc is roughly cylindrical in cross-section, but at the
lumbar level the discs are more kidney-bean shaped. Overall, their anterior
height is greater than their posterior height, so they appear wedge shaped in
sagittal  section.  The average thickness of  a  lumbar disc  is  about  10 mm. The
intervertebral disc has a soft, gel-like inner region, the nucleus pulposus (or
nucleus), that fills 30-50% of the disc cross-sectional area, surrounded by a
tough, fibrous outer region, the annulus fibrosus (or annulus) (Figure 4).
The annulus consists of lamellae of oriented collagen fibrils, enclosing the
nucleus like a tube. Although the nucleus and annulus are two distinct
structures, the boundary between them is not clearly defined; there is a gradual
transition from the mucoid texture of the nucleus to the laminated structure of
the annulus. The upper and lower surfaces of the disc consist of thin (± 1 mm)
hyaline cartilage end-plates that separate the disc from the vertebral bodies.
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Figure 4: The intervertebral disc.
The inner  lamellae of  the annulus merge into the end-plates  to  form a closed
vessel containing the nucleus, whereas the outer lamellae are attached to the
bone of the adjacent vertebral bodies (Figure 5) [11, 17, 18].
Figure 5: Exaggerated sagittal view of the vertebral end-plates and the
laminated structure of the annulus fibrosus.
The nucleus pulposus consists of a highly hydrated gel of proteoglycans, which
in turn consist of sulphated glycosaminoglycan side-chains covalently bound to
core protein. Also some collagen (mostly type II) and few cells are present.
Some of the proteoglycans aggregate by interaction of the protein core with
hyaluronic acid. The sulphate and carboxyl groups of the glycosaminoglycans
are negatively charged and are not free to diffuse out of the matrix, since they
are  part  of  a  high  molecular  weight  polymer.  This  leads  to  a  high  density  of
fixed negative charges. The fixed negative charges are electrostatically
balanced by mobile cations, e.g. Ca2+. Due to the elevated levels of mobile ions
compared to its surroundings, the nucleus has a higher osmotic pressure and as
a  result,  the  matrix  attracts  water.  In  children  and  young  adults,  the  water
content of the nucleus exceeds 80%. The water content decreases with age,
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due to compositional changes of the nucleus. The high water content makes
the nucleus easy to visualize using T2-weighted MRI [19].
The  annulus  fibrosus  is  made  up  from  about  a  dozen  concentric  layers  of
collagen fibres, the lamellae. In each lamella the fibres are parallel and tilted
about 30 degrees with respect to the disc plain; the successive lamellae are
tilted in opposite directions (Figure 6). Hence, adjacent bands are at 60 degrees
to each other. The inner annulus contains mainly collagen type II, whereas in
the outer annulus collagen type I is predominantly present. The lamellae are
thick in the anterior and lateral portions of the annulus, but posteriorly they are
finer and more tightly packed. Consequently, the posterior region is thinner
than the rest of the annulus.
The cartilaginous end-plates are composed of hyaline cartilage, which looks like
the articular cartilage of synovial joints, and fibrocartilage.
Figure 6: Detailed structure of the fibre orientations in the lamellae of the
annulus fibrosus; the 30 degree angle with the disc plane is the same, but
opposite in consecutive lamellae.
The intervertebral disc is the largest organ in the body without blood supply, so
it depends on diffusion through the end-plates and annulus from the
surrounding blood vessels, for nutrient supply and the removal of metabolic
waste products. Furthermore, by loading and unloading the disc, convective
transport of larger solutes occurs through a kind of pumping action [20-22].
3.3 Disc function
As a result of the osmotic pressure in the nucleus, enclosed by the annulus and
end-plates, the intervertebral disc is continuously pressurized. This pressure,
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the swelling pressure, in healthy discs about 0.1 MPa [23], is balanced axially
by  muscle  and  ligament  tension.  It  also  has  a  radial  component,  exerting
pressure on the annulus, in which it is balanced by tension in the annular fibres.
The swelling pressure makes the disc able to support loads, like compressed air
in a tire. This mechanism is especially efficient in resisting axial loads, which is
the  main  loading  direction  in  the  spine  [11,  17,  18].  When  an  axial  load  is
applied, the nucleus acts as an incompressible, isotropic fluid, distributing the
force evenly in all directions; pushing the annulus outward and the end-plates
apart. Hence, much of the load is transferred radially to the annulus fibres,
which are stretched as a result (Figure 7). The orientation of the annular fibres
is important in the transfer of loads from one vertebra to the other. Since the
collagen fibres are elastic, they store the energy needed to stretch them. If the
applied load is released, the elastic recoil of the collagen fibres exerts the
stored energy back onto the nucleus and the initial disc height is restored.
Figure 7: Intervertebral disc under axial compression, (A) The increased
pressure in the nucleus pushes the annulus and end-plates outward, resulting in
annulus bulging and end-plate deflection, (B) the stresses in the annulus vary
in different  directions and at different depths.
However, the disc is no perfectly sealed container and during continuous
loading some fluid is pressed out, presumably in order to dissipate some of the
potentially damaging compressive energy. Consequently, the disc exhibits
viscoelastic behaviour, like creep and hysteresis. For example, during the day,
the discs are continuously loaded and some fluid is lost. During the night, the
discs reswell. As a result people are on average 2 cm taller in the morning than
in the evening [24].
Other loads the disc has to cope with besides axial compression are tension,
torsion, bending and shear. Primarily, the oriented fibrous structure of the
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annulus is very important in these loading profiles. Off course, the in vivo loads
of the spine are very complex and are mostly a combination of these loads.
In  short,  the  discs  allow  motion  of  the  spine  and  transfer  loads  between  the
vertebrae.
4 Back pain
Back  pain  has  a  myriad  of  causes,  e.g.  mechanical,  congenital,  inflammatory,
degenerative, but mostly no definite cause-effects can be identified (90% has
non-specific back pain). Interestingly, psychosocial factors, including insurance
benefits, have been demonstrated to be more important than biomechanical
workload [9]. The intervertebral disc is considered to be a major contributor in
specific back pain [19]. Back pain occurs most frequently in the lumbar range.
So  the  lumbar  intervertebral  disc  is  one  of  the  foci  of  this  work.  Pain  occurs
mainly by physical, chemical or inflammatory innervation of the nerve roots,
branching from the spinal cord, possibly also giving the sensation of leg pain. A
plethora of pathologies of the intervertebral disc can possibly lead to pain, but
in  this  work  the  focus  is  on  the  bulging  or  herniated  disc,  in  early  stages  of
degeneration, which is a pathology that is readily detectable by MRI.
As  we  age,  the  nucleus  becomes  more  fibrous  and  the  glycosaminoglycan
content decreases . This process is called degeneration. As a result, the nucleus
becomes desiccated and the disc loses height. The boundary between nucleus
and annulus becomes even less distinct. Loss of disc height puts relatively more
axial load on the annulus fibrosus, which can weaken it. This can lead
eventually to annular bulging or even a herniation of the nucleus through a
defect in the annulus. The annulus can be partly or completely ruptured. Disc
bulge is also referred to as disc protrusion, and herniation is often called disc
prolapse (partial annulus rupture) or extrusion (complete herniation through the
annulus). Mostly, disc bulge or herniation occurs posteriorly, since the annulus
is thinnest in that region. Pure axial loading does not lead to annular defects,
instead a combination of  torsion and bending does the damage [11,  18].  The
bulging annulus or herniated nucleus can irritate the neighbouring nerves,
causing pain (Figure 8).
Another cause of disc bulge or herniation is trauma. A short heavy load,
especially in a flexed posture, can cause herniation of the nucleus through the
annulus. Mostly, the disc is already somewhat weakened by torsional injuries
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[18]. In younger persons, when the nucleus is still turgescent, the symptoms
are likely to be more dramatic [19].
Figure 8: Disc  pathologies,  (A)  bulging  disc,  (B)  disc  prolapse  and  (C)
extrusion, all causing nerve root irritation (arrow).
Back pain can also be due to a vertebral compression fracture. The vertebral
body can collapse under excessive loading, like in a traumatic car accident, or
when the bone density is decreased by osteoporosis (Figure 9). Depending on
the severity of the osteoporosis, the cause of the fracture can be simple, such
as vigorous sneezing [16]. Vertebral compression fractures occur most often at
the lower thoracic and higher lumbar levels, being a transition zone between
the relatively stiff thoracic and more mobile lumbar segments [25].
Figure 9: Vertebral compression fracture.
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5 Treatment options
5.1 Disc problems
People experiencing low back pain, due to disc problems and severe enough to
consult  a  physician,  have  several  treatment  options;  initially  an  array  of
conservative treatments, or various surgical procedures. Conservative treatment
includes: exercise, physical therapy, anti-inflammatory drugs, painkillers, and
muscle relaxants among others, although the efficacy of these treatments
remains a point of debate [2, 10, 26]. If conservative methods do not suffice to
alleviate the pain, people usually undergo surgery. In the Netherlands, about
11,000 hernia operations are performed annually, which contributes to having
the second highest  ratio  for  back surgery in  the world,  after  the US [27,  28].
Several surgical procedures for the treatment of back pain will now be
discussed:
- (Partial) discectomy or nucleotomy
This procedure involves the removal of (part of) the affected intervertebral disc
or  nucleus  pulposus  in  an  attempt  to  relieve  nerve  root  compression  [10].
Nowadays, the procedure can be performed by minimally invasive techniques;
endoscopically and percutaneously. The primary goal is to alleviate pain and as
such it does not restore the function of the disc. An alternative technique is
chemonucleolysis, in which the nucleus is chemically dissolved by the local
injection of the enzyme chymopapain. However, this alternative method is still
the subject of controversy. The results of discectomy for pain relief are good to
excellent, with a success rate of 70% to 95% in carefully selected patients. Still,
discectomy introduces mechanical instability and was found to lead to a loss of
disc height [29, 30].
- Spinal fusion
Spinal fusion is widely performed in the management of back pain [11, 31]. It is
mostly done in combination with a total discectomy. The rationale is to alleviate
pain by diminishing movement between two vertebrae and restoring disc
height. In this procedure, the spinal motion segment is immobilized by fusing
the adjacent vertebrae together. Fusion is achieved by mechanical fasteners
(screws and rods) and/or bone grafts, supplemented potentially with a cage
(Figure 10A). Although this technique is widely used, there are conflicting
reports on its effectiveness [2, 10] and many concerns about the effect on the
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adjacent  levels  [32-35].  The  adjacent  levels  will  have  to  compensate  for  the
loss of motion in the fused segment.
- Total disc replacement
After  a  total  discectomy,  a  synthetic  artificial  disc  is  placed  in  between  the
vertebrae (Figure 10B). The underlying principle is to maintain/restore the
mobility of the segment on top of the pain alleviation. In effect, it is a prosthetic
joint.  There  are  many  designs,  few  of  which  have  made  it  to  clinical  pratice,
even less were somewhat succesfull [36-38]. Examples of designs are: a solid
steel ball (earliest design) [39], all-polymeric prosthesis [40], three-dimensional
woven fabric [41],  ultra-high-molecular-weight polyethylene nucleus in
between metal end-plates [42] and many, many more. The problems that occur
most often are difficulties of anchoring the prosthesis in the vertebral bodies,
associated with implant subsidence, and the formation of wear particles capable
of eliciting an immune response [43-45]. Overall, the effectiveness is
comparable to a fusion procedure [36, 46, 47].
- Nucleus replacement
In view of the fact that it has proved to be extremely complicated to replace an
entire intervertebral disc and recognizing that it is not always necessary to
remove the annulus fibrosus, and desirable to retain the functions of the
nucleus pulposus, the idea arose to replace only the nucleus pulposus [48-50].
The troublesome nucleus is removed and replaced with a prosthesis (Figure
10C). Nucleus replacements also come in a wide variety of designs [51-54], but
the  most  promising  and  most  investigated  designs  consist  of  a  hydrogel.  The
main  advantage  of  hydrogels  is  their  capability  to  absorb  water,  which
resembles the natural nucleus. This technique as yet has not been introduced
into routine clinical  practice,  but  is  a  promising future alternative.  For  it  to  be
useful, it is important that the annulus is still functional. Device migration or
extrusion are the largest concerns with this procedure [55-57].
Figure 10: Examples  of  treatment  options,  (A)  spinal  fusion,  (B)  total  disc
replacement and (C) nucleus replacement.
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- Tissue engineering
This approach is still in its infancy. Attempts are made to regenerate the natural
disc. A cellular graft is inserted to stimulate natural repair [50, 58]. The
technique seems promising, but for this approach to be successful, there are
still  a lot of hurdles to overcome  and moreover, if the nutrition of the disc is
hampered, insertion of cells will be useless [59-62].
5.2 Vertebral compression fractures
For people suffering from symptomatic vertebral compression fractures,
secondary to osteoporosis, the focus of treatment is pain alleviation. Initially
this  is  done  with  analgesics.  If  necessary,  the  height  and  stability  of  the
affected vertebra can nowadays be restored by either vertebroplasty or balloon
kyphoplasty (Figure 11). Both procedures involve the percutaneous injection of
bone cement into the vertebral body. In kyphoplasty the cement is injected
after the inflation of a balloon in order to augment the vertebral body and
create a space for the cement. Success rates for these procedures exceed 90%
[63, 64].
Figure 11: The  injection  of  cement  into  a  collapsed  vertebral  body  during  a
vertebroplasty procedure.
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6 Our approach
6.1 Disc problems
The greatest challenge for a successful surgical procedure, especially for the
long-term, is to retain the motion in the motion segment, but also the stability.
This contradictory demand is what makes the natural intervertebral disc such a
complex joint, and hence so difficult to replace. From the surgical procedures
for the management of disc problems described above, we feel the nucleus
replacement holds most promise, and especially the hydrogel nucleus
replacement. The orthopaedic surgeons from the Academic Hospital in
Maastricht, who are often faced with the ill-effects of total disc replacement in
particular [43, 65, 66], suggested the development of a novel type of hydrogel
nucleus prosthesis. On top of the obvious demands for a nucleus prosthesis,
vide infra, they wanted the prosthesis to be intrinsically radiopaque with X-ray
fluoroscopy. To take up the challenge of designing an intrinsically radiopaque
hydrogel, we built on our knowledge of intrinsically radiopaque polymers [67]
and hydrophilic coatings [68].
As  a  start  it  is  important  to  realize  the  demands  for  a  nucleus  prosthesis.
However, to date there are no official standards describing a nucleus
replacement, but some requirements have been suggested by Bao [48, 69].
Based on these papers, some other literature sources [49, 51, 54, 70] and our
own insights, we stipulated the following demands:
1) The nucleus prosthesis should be intrinsically radiopaque and compatible
with MRI. Intrinsic radiopacity allows for complete visualization using X-rays.
This aids the surgeon in positioning the implant in the nucleus cavity. It is also
useful to evaluate the implant at a later time.
2) The nucleus prosthesis can be implanted through a small incision in the
annulus fibrosus and fills the entire nucleus cavity after implantation.
Fortunately, this is an inherent advantage of a hydrogel; it can be implanted in
the dry state, called xerogel, and swell in situ to fill the entire nucleus cavity
and restore disc height. Cavity conformity is essential to transfer compressive
loads to the annulus and distribute forces over the entire end-plates.
3)  Once in  place,  the nucleus prosthesis  should take over  the function of  the
natural nucleus. The stiffness of the prosthesis material should be tuned, to
mimic the response of the pressurized fluid under loading. When compressed, it
should expand radially to transfer the compressive force to the annulus. The
prosthesis material should be elastic and recover its height after the load is
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removed. It should also be fatigue resistant and preferably resume the pumping
action of the natural nucleus pulposus.
4) As for any material used in the human body, the material for the nucleus
prosthesis should be biocompatible.
Successful implementation of this technique also requires appropriate patient
selection, hence proper indications and contraindications are important. No
formal indications are formulated so far, but suggestions are made in literature
[48,  51,  54].  Nucleus replacements  can be used as an adjunct  to  discectomy,
since  it  is  designed  to  address  the  pitfalls  of  discectomy,  without  losing  its
benefits. It can be used as an alternative in patients who require fusion, but
who  still  have  a  tall  and  stable  disc,  which  are  mainly  young  people  in  early
stages of degeneration, or people who have experienced a traumatic herniation.
Contraindications include advanced degeneration with disc height less than 5
mm and an incompetent annulus, spondylolisthesis (forward slippage of one
vertebra over another) and Schmorl’s nodes (herniations of the nucleus through
the end-plates). Practically, the indications are dictated by benefit-to-cost and
benefit-to-risk ratios, compared to discectomy and fusion. The risk for a nucleus
replacement  is  slightly  higher  than  for  discectomy  alone,  but  less  than  for
fusion. Extra costs are associated with a nucleus replacement over a discectomy
alone.
As mentioned earlier, there are many designs for nucleus replacements. None
of  the  designs  is  commercially  available  in  the  USA  yet  and  none  so  far  are
approved  by  the  Food  and  Drug  Administration  (FDA)  [48,  54].  In  Europe
however, one design is already used clinically, while others are in clinical trials.
The most prominent examples are the Prosthetic Disc Nucleus (PDN),
developed by Raymedica Inc. (Bloomington, Minnesota, USA) [71] and the
Newcleus, developed by Sulzer Spine-Tech (Edina, Minnesota, USA) [52]
(Figure 12). The PDN consist of a polyacrylamide based hydrogel core,
surrounded by a polyethylene jacket. The Newcleus is a memory coiling spiral
made from polycarbonate urethane. The PDN has the largest human clinical
experience. The design and implantation procedure were adapted after initial
problems of device migration and end-plate damage [51, 72, 73]. The PDN has
helped to elucidate the promises and pitfalls of nucleus replacements in general
and  has  served  as  a  guiding  concept  for  the  development  of  many  nucleus
prostheses.
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Figure 12: Examples of nucleus replacements, (A) the Prosthetic Disc Nucleus
(PDN) and (B) the memory coiling spiral (Newcleus).
We  feel  that  both  the  PDN  and  Newcleus  can  be  improved  in  terms  of
radiopacity and cavity conformity; the PDN is not shaped to fit the kidney-bean
shaped nucleus cavity exactly and relies on metallic markers for radiographic
visualization,  and  the  Newcleus  is  also  not  a  perfect  fit  and  is  radiolucent
(Figure 13).
Figure 13: Visualization of nucleus replacements using X-Ray and MRI, (A)
plain X-ray image of the PDN in between two vertebrae showing small
radiopaque markers, (B) axial MRI of the PDN in situ, (C) axial CT-image of an
intervertebral disc containing the radiolucent Newcleus and (D) axial MRI of the
Newcleus in situ.
The concerns for a nucleus prosthesis, being implant migration and extrusion
can potentially be avoided by cavity conformity of the prosthesis and repair of
the annulus. For annulus repair, a tissue engineering strategy might be
employed, however this falls outside the scope of this thesis.
6.2 Vertebral compression fractures
Acrylic bone cements used in total joint replacements are made radiopaque by
the addition of inorganic contrast agents, with its inherent drawbacks. Bone
cements consist of a liquid and a powder, which are mixed before use [74].
Acrylic monomer and accelerator constitute the liquid phase, and polymer
microspheres, the initiator benzoyl peroxide (BPO) and contrast agent represent
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the powder phase. Mixing both phases initiates polymerization and consequent
hardening of the cement by combining initiator and accelerator. The polymer
microspheres slightly dissolve and become part of the polymerizing matrix. The
inorganic contrast agents just reside within the matrix and have a tendency to
form lumps. These lumps are known to act as crack-initiation sites [75].
Also in vertebroplasty and kyphoplasty, these radiopaque acrylic bone cements
are mostly used. However, the required X-ray contrast is higher for these
procedures for improved fluoroscopic visualization. This is achieved by
increasing the amount of inorganic contrast agents, with its concomitant
disadvantages. For total joint replacements the amount of inorganic contrast
agent  in  the  powder  component  of  the  cement  is  10-15  wt.%,  whereas  for
vertebroplasty and kyphoplasty 30 wt.% must be used [76]. With our existing
knowledge on intrinsically radiopaque bone cement, we also hope to develop a
viable alternative for the augmentation of vertebral compression fractures.
When using acrylic bone cement for these applications, besides the elevated
contrast level, the cement needs to be less viscous for injection through a 10-
15 gauge needle [77, 78], and it needs to have a longer working time.
Commonly this is achieved by increasing the liquid-to-powder ratio [79, 80] and
decreasing the amount of initiator.
6.3 Intrinsic radiopacity
The X-ray absorption of a material at a certain photon energy is dependent on
its  thickness,  density  and  elemental  composition,  as  is  clear  from equation  1,
which relates the X-ray intensity leaving the object (I) to the incident intensity
(Io), at a single photon energy [81, 82]:
])/([ x
o eII
rm-×= (1)
in which x is  the  material  mass  thickness  and  (???) is the mass attenuation
coefficient (? is the linear attenuation coefficient and ? is the density). This
coefficient tends to increase with increasing atomic mass. Absorption is mainly
achieved by the collision of the X-ray photons with the electrons in a material.
Hence, the absorption is higher when the concentration of electrons is higher.
Elements with high atomic numbers have high electron densities. Water, with
the  lower  elements  H  and  O,  has  low  X-ray  absorption,  so  any  structure
containing a significant amount of it, is by definition radiolucent. Most organs
and hydrogels are therefore not visible by X-ray fluoroscopic imaging. Polymers
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consist primarily of the lower elements C, H, O and N, so they have very little X-
ray absorption. Polymeric biomaterials therefore often require the addition of
contrast agents. Medical materials that are required to be radiopaque, either
contain metals or inorganic contrast agents (e.g. barium sulphate, zirconium
dioxide). The best known example is acrylic bone cement, used for the fixation
of total joint replacements, which is mostly made radiopaque by the addition of
barium  sulphate.  However,  the  addition  of  contrast  agents  leads  to  an
inhomogeneous structure, introducing mechanical weakness in the material [75,
83]. Furthermore, inorganic contrast agents in bone cements are associated
with bone resorption [84, 85], which is particularly undesirable in osteoporotic
persons. Also for a hydrogel nucleus replacement, the addition of a powder, like
barium sulphate, is not an option, since it can leach out once the gel is swollen.
A disadvantage of the implementation of metallic markers is its incompatibility
with  MRI,  leading  to  artefacts  in  the  image.  Since  imaging  techniques,  like
computed tomography (CT) and MRI, are increasingly important, an implant
ideally is compatible with both modalities.
To make polymeric biomaterials radiopaque, without the drawbacks of contrast
agents  and metallic  markers,  it  is  possible  to  introduce a high atomic  number
halogen  into  the  polymer.  For  this  purpose,  a  methacrylic  monomer  was
synthesized, containing covalently bound iodine (atomic number = 53) [86].
This monomer, 2-(4’-iodobenzoyl)-oxo-ethyl methacrylate (4IEMA; Figure 14),
is readily copolymerized with other methacrylates to yield random copolymers.
This way, X-ray absorption is incorporated in the polymer, rendering it
intrinsically radiopaque  and  compatible  with  both  CT  and  MRI.  Moreover,
making an implant material intrinsically radiopaque allows complete
visualization of the implant, this in contrast to the addition of metallic markers.
The stability of these iodine-containing polymers was demonstrated in vivo
[87].
Figure 14: Structural formula of 4IEMA.
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In this work, iodine-containing polymers were used to develop (1) intrinsically
radiopaque hydrogels for nucleus pulposus replacement by combining 4IEMA
with hydrophilic monomers and (2) a highly radiopaque acrylic bone cement for
use in vertebroplasty or kyphoplasty, by replacing the inorganic contrast agent
with iodine-containing polymer microspheres.
7 Outline and aim of this thesis
With this thesis I hope to contribute to the field of spinal surgery and provide
surgeons with viable alternatives in the management of back pain. It describes
the attempt to design a new kind of prosthesis for the nucleus pulposus and the
development of an all-polymeric bone cement for the augmentation of vertebral
compression fractures.
Since nucleus replacement is an emerging technology, a lot of research in this
area  is  done  at  the  moment,  resulting  in  several  designs,  all  building  on  the
pioneering work of the PDN. In our view, most designs have two major flaws,
which we wanted to address; nucleus replacements feature insufficient
radiopacity and their shape is not in conformity with the nucleus cavity. To
achieve a hydrogel implant with intrinsic radiopacity, we combined existing
knowledge in our lab from two main research themes, being hydrogel coatings
and intrinsically radiopaque polymers. Chapter  2 describes the initial
investigation of copolymerizing a hydrophobic radiopaque monomer with
hydrophilic monomers, attempting to create radiopaque hydrogels. Several
properties of the resulting materials, important for the intended application,
were investigated. This included water content, stiffness, cytotoxicity and
radiopacity. The work resulted in the selection of two materials that seemed
promising to serve as nucleus replacements. These two materials were further
investigated for their implantability, biocompatibility and radiopacity in situ, as
described in Chapter  3. Recognizing that the materials had to be fine-tuned
further in order to serve as functional nucleus replacements, the composition
was slightly altered and a chemical crosslinker was introduced. Chapter 4 then
deals with the comparison of the modified and crosslinked materials versus the
earlier two materials, and their evaluation on several mechanical properties,
important for a functional nucleus prosthesis.
Also, we developed a highly radiopaque iodine-containing bone cement for use
in either vertebroplasty or kyphoplasty. This new cement was evaluated for a
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wide array of properties, relevant for the intended application, and is described
in Chapter 5.
In Chapter 6 we discuss the implications of both the new nucleus prosthesis
and the new cement for the field of spinal surgery and the management of back
pain. We will also devise recommendations for future perfection of both
appliances.
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Abstract
Degeneration of the intervertebral disc is the most common cause of back pain.
In case of early stage degenerative disc disease or traumatic herniations, a
suitable treatment may be to replace the nucleus pulposus, preserving the
annulus fibrosus. Eight new hydrogel biomaterials were prepared and studied
for their potential as a nucleus replacement. The hydrogels were designed
according to the following criteria: (i), they should exhibit adequate radiopacity;
(ii),  they  should  be  non-cytotoxic;  (iii),  implantation  in  the  dry  state  and
subsequent swelling in situ to fill the entire nucleus cavity; (iv), after swelling
they should match the physical-mechanical properties of the native nucleus.
The approach was to use copolymers consisting of 2-(4’-iodobenzoyl)-oxo-ethyl
methacrylate (4IEMA) and a hydrophilic building block (either N-vinyl-2-
pyrrolidinone (NVP) or 2-hydroxyethyl methacrylate (HEMA)); 4 copolymers of
NVP/4IEMA and 4 copolymers of HEMA/4IEMA in different compositions (5, 10,
15 and 20 mol% 4IEMA).
The study comprised 1H-NMR analysis of the copolymerization reaction NVP +
4IEMA. Furthermore, the copolymers were studied with respect to their swelling
behaviour, mechanical properties, cytotoxicity in vitro and X-ray contrast.
Hydrogels  with  5  mol%  4IEMA  appear  to  meet  all  criteria:  they  are  non-
cytotoxic, have adequate physical-mechanical properties and feature sufficient
radiopacity in a realistic model. The potential implications of these new results
with respect to treatment of degenerative disc disease are discussed briefly.
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1 Introduction
Back pain is the largest cause of lost work days and activity limitation in
western countries for people younger than 45 years [1, 2]. The most common
cause is degeneration of the intervertebral discs (IVDs) [3]. Various
conservative treatment options are available. When these fail to alleviate the
pain, surgical intervention is often inevitable. Two common operations are: (i)
removal of the damaged IVD(s) (discectomy) and/or spinal fusion, or (ii)
replacement of the IVD with a prosthetic disc [4]. The first option is primarily
concerned with alleviating pain, whereas the latter is also focused on restoring
function. The structural and functional complexity of the IVD makes it hard to
match Nature’s design. There is a wide variety of prosthetic discs [5], but only
few have made it to clinical use and even less were somewhat successful.
In  some  cases,  back  pain  originates  from a  traumatic  rupture  of  the  annulus
fibrosus, in such a way that the defect allows herniation of the nucleus
pulposus. Then, adequate treatment may be to remove the herniated nucleus
and replace it with a prosthetic implant, followed by closure of the annulus
defect e.g. via a tissue engineering strategy. This treatment can also be
suitable to help patients with early-stage disc degeneration. Replacing only the
nucleus has several advantages over (i) and (ii) as it is less invasive, and the
remaining disc tissues, i.e. the annulus and the endplates, are preserved, as
well as their functions [3, 6]. The height and mobility of the IVD are maintained
and overloading of the adjacent levels, which is often a result of spinal fusion, is
prevented.
The natural nucleus pulposus is a gelly substance. Its water content is > 80%
in children, and is shown to decrease gradually with age [7]. Its main function,
as part of the IVD, is to provide flexibility to the spine. The material of choice to
replace the damaged nucleus pulposus would be a synthetic hydrogel.
Numerous  synthetic  hydrogels  are  known,  most  of  them have  a  high  level  of
biocompatibility, and their physical-mechanical properties can be tuned to
mimic the behaviour of the natural nucleus [8, 9]. A prominent example is the
Prosthetic Disc Nucleus (PDN), developed by Raymedica Inc. [10-14]. One of
the shortcomings of the PDN may be that it does not completely fill the cavity
left by the removed nucleus. Filling the cavity entirely is essential to achieve a
physiological stress distribution within the disc [15, 16] and to minimize implant
migration.
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The success of a nucleus replacement is also largely dependent on the correct
positioning of the implant. To assess adequately the location of the implant
during and after surgery, it is convenient that it can be monitored real-time
using X-ray fluoroscopy. That way the surgeon is able to perfectly position the
implant  in  the  nucleus  cavity.  Also,  in  case  of  complications  arising  at  a  later
time, the implant can be easily traced.
Herein, we report initial studies on new hydrogel biomaterials with potential
utility as a nucleus prosthesis. For this, four criteria were defined: (1) The
hydrogel prosthesis should exhibit intrinsic radiopacity; (2) The hydrogel
prosthesis should be non-cytotoxic; (3) The prosthesis, being implanted in dry
form (which is relatively small) should swell in situ to fill the entire cavity that is
left after complete removal of the nucleus; (4) In the swollen state, the
physical-mechanical properties of the prosthesis should match those of the
native nucleus as closely as possible.
Our strategy to meet these criteria was based on the use of copolymers, which
are synthesized from a hydrophilic building block (either N-vinyl-2-pyrrolidinone
(NVP) or 2-hydroxyethyl methacrylate (HEMA)) and a hydrophobic iodine-
containing building block, i.e. 2-(4’-iodobenzoyl)-oxo-ethyl methacrylate
(4IEMA; Figure 1) [17-20]. The iodine in the 4IEMA is covalently bound and
renders the copolymers intrinsically radiopaque, while the ratio hydrophilic :
hydrophobic determines important characteristics such as swelling behaviour
and stiffness.
Eight different hydrogels were prepared, characterized and studied with respect
to their biocompatibility, X-ray contrast and physical-mechanical properties,
while keeping in mind the suitability for use as nucleus pulposus substitute.
Figure 1: Structural formula of 4IEMA.
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2 Materials and methods
2.1 Materials
All chemicals were purchased from Acros (Landsmeer, The Netherlands). NVP
and HEMA were distilled under reduced pressure to remove inhibiting additives.
The monomer 4IEMA was synthesized from 4-iodobenzoyl chloride and purified
HEMA  [17].  Purity  and  identity  of  all  monomers  was  checked  by 1H-NMR
spectroscopy. 2,2'-azobis(isobutyronitrile) (AIBN) was used as the source of
free radicals. Monomers and 0.044 mol% of AIBN were mixed and transferred
to  Teflon  tubes  with  an  inner  diameter  of  12  mm,  which  were  closed  with  a
stopper on one end. Then they were immersed in a thermostated oil bath. A
temperature  profile  was  run  that  keeps  the  oil  bath  for  8  hours  at  60  °C,
followed by 4 hours at 80 °C and another 4 hours at 100 °C.
Polymerization resulted in transparent, glassy rods. Eight different copolymers
were prepared and their composition will be indicated in codes: a letter
followed by a number indicating respectively the hydrophilic monomer (NVP or
HEMA) and its molar percentage; e.g. N95 is a copolymer of 95 mol% NVP and
5 mol% 4IEMA. The prepared copolymers are N95, N90, N85, N80, H95, H90,
H85 and H80.
2.2 Copolymerization of NVP and 4IEMA
The reaction of NVP + 4IEMA was studied according to the method of Kruft et
al. [21]. Monomer mixtures of NVP and 4IEMA (0.09, 0.14, 0.18, 0.32, 0.43,
0.52 molar fraction 4IEMA) and 0.1 mol% AIBN were dissolved in DMSO-d6 (1.5
mmol/mL).  About  700 ?L was transferred into a  5 mm diameter  NMR tube.  A
1H-NMR spectrum (Varian Unity-Plus, 400 MHz) was taken at room temperature
to check purity and composition of the monomer mixture. Subsequently the
sample was rapidly  heated to 70 ºC inside the magnet. 1H-NMR spectra were
taken every 3 minutes to follow the polymerization reaction.
The glass transition temperature (Tg)  of  the  materials  in  the  dry  state  was
measured on a Perkin Elmer Pyris 1 DSC at a heating rate of 10 K/min.
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2.3 Swelling
To study the water uptake of the different materials, swelling experiments in
phosphate buffered saline (PBS) were conducted in triplo, using sample discs
with  a  diameter  of  12  mm  and  a  thickness  of  2  mm.  Material  masses  and
dimensions of the discs were measured at different time intervals. The excess
of water from the surface was removed before the samples were weighed. After
weighing, the samples were put back in fresh, ample PBS. The water content
(WC) was calculated using equation 1.
s
ds
m
mm
WC
-
´= 100 (1)
ms is the mass of the swollen sample and md  is the mass of the dry sample.
Also the swelling ratio was determined, which is defined by the increase in
volume: the volume of the swollen sample in equilibrium, divided by the volume
of the dry sample.
2.4 Cytotoxicity
The cytotoxicity of the materials was evaluated. Therefore, fragments of the
samples were UV-sterilized and incubated in medium for 3 days at 37 °C. The
medium, with the extracts  of  the samples,  was put  on 3T3 mouse fibroblasts
and  cell  viability  (the  cell  survival  in  pure  medium  was  set  to  100%)  was
checked after  4  days of  culturing (37 °C,  5% CO2)  using the MTT assay [22,
23]. Direct-contact tests were performed with 3T3 mouse fibroblasts on the
materials surface of 1 cm diameter discs. Glass slides were used as a reference.
The  amount  of  cells  on  the  materials  surface  was  approximately  5  ×  105
cells/cm2. The Live/Dead assay (Molecular Probes, Reduced Biohazard
Viability/Cytotoxicity Kit #1 (L-7013)) was used to evaluate adhering cells after
24 h by fluorescence microscopy (Nikon Eclipse E800 equipped with a Coolsnap
camera (RS Photometric, USA)) [24].
2.5 X-Ray opacity
X-ray visibility  was checked by taking an X-ray photograph (40 kV,  4  mAs)  of
the swollen discs, used in the swelling experiments. As a pilot study, dry oval
samples (2.5 mm thick) of H95 and H90 were inserted into a nucleus cavity of
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the lumbar spine of a porcine cadaver by a certified orthopedic surgeon and
after overnight swelling X-ray photographs were taken of the materials in situ at
clinical conditions (66 kV, automatic exposure). This provides a realistic model.
2.6 Static mechanics
To  determine  the  Young’s  modulus  of  the  swollen  hydrogels,  a  static
compression experiment was performed in which swollen samples of ca. 8 mm
thickness and ca. 15 mm diameter were used. Three samples of each material
were, at room temperature, loaded to about 80% compression at a true strain
rate of  3  × 10-3 s-1, on a MTS 810 servo-hydraulic tension-compression tester
using  a  25  kN  load  cell. Compression was stopped as soon as cracks were
observed.
2.7 Rheology
To assess the rheological properties of the designed hydrogels, rheological
experiments were performed on swollen discs (diameter 8 – 16 mm, thickness
1.2 mm) using a parallel plate viscometer (ARES 3LSLC1, Rheometric Scientific)
at room temperature. The samples were compressed to a normal force of
around  0.5  N.  First  a  strain  sweep  (0.005%  -  0.5%)  was  performed  at  an
angular  frequency  of  1  rad/s  on  samples  with  a  high  (N80)  and  low  (N95)
modulus to determine the region of linear viscoelasticity. From this experiment
it was conducted that a strain of 0.01% was in the linear viscoelastic region of
both materials. Therefore, the dynamic frequency experiments of all samples
were performed at this strain.
2.8 Hysteresis
Cyclic compression experiments were conducted to investigate the elastic
behaviour of the hydrogels for physiologic strains. Sample sizes were the same
as  for  the  static  experiment.  It  was  hypothesized,  based  on  average  disc
stiffness  and  minimum disc  strength  for  an  artificial  disc  [25],  that  a  nucleus
prosthesis should be able to withstand 30% compression without plastic
deformation. Material samples were compressed to 30% within 10 seconds and
then the tester (MTS 810) returned in 10 seconds to the starting position. This
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was repeated 10 times and a duplicate was performed. The materials were not
constrained radially.
3 Results and discussion
3.1 Copolymerization of NVP and 4IEMA
From our previous work on the free radical copolymerization reaction HEMA +
4IEMA, the reactivity ratios are known: r4IEMA = 2.18 ± 0.72, rHEMA = 2.29 ±
0.38) [21]. Both r values are close to unity, which implies that the HEMA/4IEMA
copolymers are random-type. NVP is known to be significantly less reactive than
methacrylate monomers. For example, the reactivity ratios of the
copolymerization of methyl methacrylate (MMA) + NVP are rMMA = 3.95 and rNVP
= 4.3 × 10-3 (calculated using Q and e values from Greenley [26]).
We decided to study the free radical copolymerization NVP + 4IEMA in detail,
following the 1H-NMR method as described by Kruft et al [21]. Six reactions
were run, each starting with a different feed composition. A series of 1H-NMR
spectra was recorded during each reaction; each acquisition took approximately
20 sec.
As a typical example, Figure 2 shows expansions of the 1H-NMR spectra which
were recorded for f4IEMA = 0.43 (molar fraction 4IEMA). Figure 2A refers to the
start of the reaction (0% conversion); Figure 2B refers to 15% conversion. Note
the broadened peaks a1’ and a2’ (? 7.8 ppm and ? 7.7 ppm) which correspond
to the aromatic protons of built-in 4IEMA. The spectra were analyzed as
described in Appendix 2. The reactivity ratios were determined at ca. 5%
conversion (i) and ca. 15% conversion (ii). Both approaches resulted in
comparable values for r4IEMA and rNVP: Method (i): r4IEMA = 5.4 ± 0.79 and rNVP =
0.04 ± 0.03. Method (ii): r4IEMA = 4.7 ± 0.32 and rNVP = 0.04 ± 0.006.
The r values clearly demonstrate that 4IEMA is much more reactive than NVP.
Noteworthy, the r values  for  the  reaction  of  NVP  +  4IEMA  are  in  good
agreement with the r values calculated using the Q and e values from Greenley
[26]  for  the copolymerization of  MMA and NVP (rMMA = 3.95 and rNVP = 4.3 ×
10-3).
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Figure 2: Expansion  (? =  5.4-8.0  ppm)  of  the  400  MHz 1H-NMR  spectra  of
monomer mixture NVP/4IEMA (f4IEMA=0.43) at (A) 0% conversion and (B) 15%
conversion. Assignments are as follows: a1 and a2: aromatic protons of 4IEMA;
a1’ and a2’: aromatic protons of built-in 4IEMA; b: vinyl proton of NVP; c1 and
c2: vinyl protons of 4IEMA.
Figure  3  compiles  the  data  from  the  analyses.  The  composition  of  the
copolymer (F) is plotted as a function of the monomer feed composition (f).
The curves from analyses (i) and (ii) deviate substantially from the diagonal,
reflecting that 4IEMA is consumed preferentially. Moreover, it is clear that the
curves resulting from analyses (i) and (ii) almost coincide.
It  can  now be  concluded  that  our  materials  N80,  N85,  N90  and  N95  are  not
random-type  copolymers.  It  must  be  assumed  that  most  of  the  4IEMA
monomer molecules are consumed at low conversion. In other words, at high
conversion, the reaction involves incorporation of (predominantly) NVP
molecules, resulting in NVP oligomers.
Figure 3: Copolymer composition as a function of monomer feed.
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1H-NMR spectra of the copolymers NVP/4IEMA, dissolved in DMSO-d6, show the
presence of unreacted NVP (2 mol%), but no unreacted 4IEMA. The presence
of residual monomer prompted us to wash each sample in distilled water, prior
to  all  further  analyses.  After  washing the samples,  the weight  loss  was larger
than expected on basis of residual monomer dissolution. It was therefore
concluded that also NVP oligomers dissolve during washing, which was also
seen by others [27]. As a result, the ratios NVP/4IEMA have changed and the
new ratios can be calculated, based on the difference in mass between the
dried, washed and the original samples. The new molar ratios are: N95: 93/7,
N90: 85/15, N85: 77/23, N80: 69/31. The copolymer composition after washing
was corroborated by 1H-NMR analysis. Futher confirmation was derived from
DSC experiments. For all compositions, a single Tg has been measured,
suggesting that a homogeneous system is obtained. For such homogeneous
system, where no separate domains of homopolymer are present, the Fox
equation [28] can be used to predict the Tg. Based on a Tg of 179 °C for PVP
[29] and 75 °C for P4IEMA [30], the theoretical glass transition temperatures
are predicted and compared to the measured Tg’s  of  the  washed  and
subsequently dried copolymers (Table 1). The measured values are indeed very
comparable to the predicted values, validating the assumption that the weight
loss can be fully ascribed to loss of NVP monomers and oligomers. 1H-NMR
spectra of the washed and subsequently dried NVP/4IEMA copolymers show no
residual monomer anymore.
Table 1: Glass transition temperatures (ºC).
Code Measured Predicted
N95 155 154
N90 139 135
N85 124 121
N80 116 111
Based on the reactivity ratios, the copolymers of HEMA and 4IEMA are assumed
to be random-type. The HEMA/4IEMA copolymers appeared to be insoluble in
all  solvents,  probably  due  to  a  high  molar  mass  and  physical  and  chemical
crosslinking [31-33]. Therefore no 1H-NMR spectra could be taken. We decided
to give the HEMA/4IEMA copolymers exactly  the same wash treatment  as  the
NVP/4IEMA copolymers. However, unlike the NVP-based copolymers, no mass
loss was observed while washing.
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3.2 Swelling
The volume increase and the water uptake of the eight different copolymers
were determined by swelling discs of the copolymers in PBS at room
temperature. Figure 4 shows the water content vs. time for the 8 different
copolymers. The NVP-based hydrogels have a higher water content than the
HEMA-based hydrogels, confirming that NVP is more hydrophilic than HEMA. It
also follows that  the hydrophobic  nature of  4IEMA has a drastic  effect  on the
water uptake of the hydrogels; for both types of hydrogel, the water content
decreases significantly going from low to high 4IEMA content. Also the rate at
which the hydrogels imbibe water depends on the hydrophilic character of the
hydrogel. Whereas for the more hydrophilic hydrogels (N95, N90, N85)
equilibrium water content (EWC) is reached in about 12 hours, the less
hydrophilic  hydrogels  take  2  days  or  more  to  reach  equilibrium swelling.  The
swelling ratios were determined by measuring sample volume (based on
thickness and diameter), before and after swelling. Swelling ratios are: N95:
4.5, N90: 2.9, N85: 2.0, N80: 1.4, H95: 1.6, H90: 1.6, H85: 1.3, H80: 1.2.
These swelling ratios can be used to calculate the size of the nucleus prosthesis
before implantation, based on the dimensions of the nucleus cavity.
Figure 4: Swelling curves of the copolymers in PBS at room temperature.
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3.3 Cytotoxicity
The possible cytotoxicity of our materials (after washing) was assessed through
the  MTT  test  and  the  Live/Dead  assay.  The  results  of  the  MTT  tests  are
displayed in Figure 5. The NVP-based hydrogels are non-cytotoxic, whereas the
HEMA-based hydrogels seem to become somewhat cytotoxic upon decreasing
their hydrophilicity. Figure 6 shows micrographs that were obtained with the
Live/Dead assay. These data were not treated quantitatively. All surfaces
contain mostly live (green) cells and only a few dead (red) cells, indicating
excellent biocompatibility of the hydrogels in direct contact with cells. It is seen
that the cells prefer less hydrophilic surfaces. Cells on the most hydrophilic
materials (N95, N90, N85 and H95) tend to form clusters.
Figure 5: Cell survival of 3T3 mouse fibroblast cells as measured with the MTT
assay. Cell survival in medium was set to 100%.
Intrinsically Radiopaque Hydrogels for Nucleus Pulposus Replacement | 45
Figure 6: Fluorescent images resulting from the Live/Dead staining assay of
3T3 mouse fibroblast cells in contact with the hydrogels.
3.4 X-Ray opacity
Figure 7 shows the X-ray absorption image of the 8 hydrogels in their swollen
state. Increasing the iodine content from H95 to H80 and from N95 to N80
clearly leads to improved contrast. To answer the question whether the level of
contrast of the gels would be sufficient for imaging inside the spinal column, we
decided  to  do  a  preliminary  experiment,  in  which  the  materials  H95  and  H90
were implanted at two adjacent levels between two vertebrae of a porcine
cadaver. Figure 8 shows the resulting X-ray image, which was recorded under
routine hospital conditions. Three intervertebral structures are seen: the native
disc (*) below, gel H90 in the middle and gel H95 on top. The native discus is
seen as a non-absorbing (white) band, while H95 and H90 are clearly visible as
X-ray  absorbing  structures.  It  can  be  concluded  that  5  mol%  4IEMA  already
introduces adequate X-ray visibility.
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Figure 7: X-ray image of swollen hydrogel discs recorded at 40 kV.
Figure 8: X-ray  image  of  two  hydrogels  implanted  in  an  IVD  of  a  porcine
cadaver,  recorded  at  clinical  conditions  (66  kV).  *  indicates  an  intact
intervertebral disc.
3.5 Static mechanics
The water in the hydrogels has a plasticizing effect and decreases the stiffness
of the copolymers. Compression experiments were performed to determine the
Young’s moduli of the swollen hydrogels. The results of these compression
experiments are depicted in Figure 9. Dehydration effects were assumed to be
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minimal  in  the  time  span  used  for  compression.  H85  and  H80  samples  were
omitted in this and further experiments; their water content is too low for the
intended application.
Figure 9: Stress-strain relationships obtained at a true strain rate of 3 × 10-3
s-1. x indicates that cracks were observed and compression was stopped.
The  Young’s  modulus  is  calculated  within  the  region  of  linear  elastic
deformation. The calculated Young’s moduli for all samples are shown in Table
2. For both the NVP and HEMA-based hydrogels, a decrease in Young’s modulus
is observed with increasing concentration of the hydrophilic component.
Table 2: Hydrogel Young’s moduli.
Code E (MPa)
N95 1
N90 24
N85 123
N80 250
H95 3
H90 13
Finite element analyses have been performed by various groups and the
Young’s modulus used to model the nucleus is in the range of 0.2 - 4 MPa [16,
34-37]. This modulus should result in a physiological stress distribution. The
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compositions of both the NVP- and the HEMA-based hydrogels can be tuned to
the desired modulus range. Both N95 and H95 are already within that range.
3.6 Rheology
The rheological properties of the natural human nucleus pulposus were
determined by Iatridis et al. [38]. They found the magnitude of the complex
shear  modulus  to  be  11  kPa  and  the  phase  angle  to  be  24  degrees  at  an
angular frequency of 10 rad/s. To compare our hydrogels with the natural
nucleus, rheology experiments were performed.
The resulting complex shear modulus G* and phase angle ? are depicted
respectively in Figure 10A and Figure 10B. In these figures the data of Iatridis
[38] are also shown (NP).
In general, G* decreases going from the glassy state to the rubbery state and
reaches a constant value in the rubbery plateau. For the NVP-based hydrogels,
the complex shear modulus is more or less independent of the frequency,
implying that the hydrogels are in the rubbery plateau at the applied
frequencies. On the other hand, for the HEMA-base hydrogels, the variation in
G* is about one order of magnitude, indicating that the rubbery plateau is not
yet reached. This suggests that the glass transition temperature of the HEMA-
based hydrogels is close to room temperature. Since it is impossible to
determine the Tg of  hydrated  hydrogels  using  DSC,  due  to  the  small  range
between the freezing and evaporation of water, it is tried to assess the Tg,
based on the theoretical Tg of  water  (-138  °C  [39])  and  the  Tg’s  of  the  dry
copolymers H95 (100 °C) and H90 (93 °C). These were determined analogous
to the Tg’s of the NVP-based copolymers. Using the EWC and the Fox equation,
the theoretical  glass  transition is  -7.6 °C for  H95 and 18.2 °C for  H90.  These
values are indeed close to room temperature and this explains the frequency
dependence of G*.
Passing Tg,  upon going from the glassy to  the rubbery state, the phase angle
shows a maximum and decreases towards the plateau-region. Like for the
modulus, relatively large frequency dependence is observed for the phase angle
of the HEMA-based hydrogels. The phase angle decreases from about 55
degrees to 12 and 40 degrees for H95 and H90 respectively. For the NVP-based
hydrogels, the phase angle is much less dependent on the frequency and is on
average between 8 and 16 degrees. Low values of the phase angle ? indicate
very elastic behaviour.
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Figure 10: Rheological spectra from a dynamic shear experiment at 0.01%
strain; (A) complex shear modulus G*, (B) phase angle ?.
From  the  lower  complex  shear  modulus  of  the  natural  nucleus  (104 Pa)
compared to that of the hydrogels (105-107 Pa),  it  can be concluded that  the
natural  nucleus  has  a  more  fluid  consistency  as  compared  to  the  soft  solid
character of the tested hydrogels. This result is in agreement with the finite
element  analysis,  where it  is  also shown that,  to  obtain  a  physiological  stress
distribution, the synthetic nucleus should have a more solid-like character than
the natural nucleus.
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3.7 Hysteresis
The natural nucleus pulposus is exposed to continuous cyclic loading. A
preliminary cyclic compression experiment was performed to evaluate the
response of the hydrogels on cyclic loading. The experiment involved 10 loading
cycles to minimize dehydration effects. In this experiment N80 was also left out,
because of its high stiffness. Results of N95, N90, H95, H90 are displayed in
Figure 11A and 11B. Results of N85 are not shown, but are comparable to N90,
only  the  maximum  stress  is  higher  (6  MPa).  Of  course  the  amount  of
compression of the nucleus prosthesis is determined by the load it is subjected
to and the stiffness of the implant material. Here we compressed to 30%, but
since all materials have a different stiffness, different forces are needed to
achieve this strain. After a number of cycles, the hysteresis loops become
repeatable, the materials are then preconditioned. Both N90 and H90 are
considerably deformed during the first cycle, whereas N95 and H95 only deform
to a small extent. It was noticed that, when given more time to recover in PBS,
H90 returned almost fully to its original height. Clearly, these experiments
provide only a first impression of the hysteresis characteristics. More extensive
investigation on long-term fatigue of our hydrogels, submerged in PBS, is
planned.
Figure 11: Hysteresis curves from a dynamic compression experiment, in
which the hydrogels were compressed from 0 to 30%; (A) NVP-based
hydrogels, (B) HEMA-based hydrogels. 1 indicates the first cycle.
The area enclosed by a hysteresis loop is a measure for the dissipated energy.
The energy dissipation of the HEMA-based hydrogels is larger than the energy
dissipation of the NVP-based hydrogels, which is consistent with the higher
phase angle found for these materials in the rheology experiments.
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Since N95 and H95 are within the desired stiffness range, it is expected that the
stresses acting on them are representative for the natural situation. If these
stresses (up to 0.4 MPa) would be applied on N90 and H90,  the compression
would be small  and they would only  deform elastically,  since these forces are
within their region of linear elasticity.
4 Concluding remarks
This study reveals that biocompatible, radiopaque hydrogels can be
manufactured in such a way that they have adequate physical-mechanical
properties to serve as a prosthesis for the nucleus pulposus. From the set of 8
different radiopaque hydrogels (N95, N90, N85, N80, H95, H90, H85, H80), the
materials  N95  and  H95  appear  to  be  most  suitable.  Swelling  ability  and
rheological behaviour of N95 favors it above H95. N95 swells by 78% vs. 23%
for  H95,  consequently  N95  is  smaller  in  dry  form  and  thus  easier  to  implant
through a minimal incision in the annulus.
We foresee that radiopaque hydrogels as described here are attractive
materials for replacement of a herniated nucleus pulposus, especially in those
cases which allow for repair of the annulus ring: the annulus will be sutured or
closed  via  a  tissue  engineering  strategy.  It  is  also  conceivable  that  the
radiopaque hydrogels are useful as an alternative to the Prosthetic Disc Nucleus
of Raymedica, offering the advantage of intrinsic radiopacity (i.e. the implants
are completely visible, and no X-ray markers are needed). Noteworthy, the new
hydrogels can also be visualized readily and without artifacts by means of MRI
[18]. Our future investigation will include fatigue testing and animal
experiments. Also, implant geometry and implantation techniques will have to
be studied to achieve a perfect fit of the implant in the nucleus cavity.
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Abstract
Treatment of early degenerative disc disease can, in some cases, be
accomplished through implantation of a synthetic prosthesis for the nucleus
pulposus. This treatment is attractive, since the annulus fibrosus -as well as the
function of the disc- is preserved. This study reports on two new synthetic
hydrogels which were specifically designed as fully radiopaque prosthetic
nucleus biomaterials.
Moreover, the new materials were engineered in such a way that they swell in
situ (i.e. after implantation) to such an extent that they will fill the entire
nucleus cavity. We describe: (i) assessment of the biocompatibility of the new
biomaterials in an in vivo animal model, (ii) implantation of the new prosthesis
in an ex vivo animal model (porcine spine), followed by (iii), assessment of the
visibility of the entire nucleus prosthesis through both CT and MRI. The results
further substantiate the idea that the concept of implantation of a prosthesis for
the nucleus pulposus can benefit from contemporary insights and developments
of novel synthetic biomaterials with intrinsic radiopacity.
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1 Introduction
Degenerative  disc  disease  (DDD)  is  one  of  the  most  common  indications  in
spinal surgery. Currently, there is no real ‘golden standard’ to treat DDD.
Nonoperative treatment has many proponents, presumably since operative
treatment  of  DDD is  usually  complicated and the outcome may be unsure.  In
general, operative treatment of DDD implies spinal fusion: (part of) the affected
disc is removed and the adjacent vertebrae are connected with mechanical
fasteners. The separation of the vertebrae is usually secured with a cage or
with an autologous or allograft bone graft. Spinal fusion however, locally
impairs the range of motion of the spine. Consequently, neighboring segments
are  called  upon  to  compensate  for  the  immobilized  section,  and  this  might
result in further problems [1-5].
An alternative treatment has emerged for patients with mild (early) DDD or for
some trauma cases. This treatment is based on an implant that is designed to
replace the diseased or deformed nucleus pulposus, and to mimic the function
of the natural healthy nucleus pulposus, while preserving the annulus fibrosus
[6-9]. Nucleus replacement is a minimally invasive procedure. In order to be
considered for a nucleus replacement, certain inclusion criteria must be fulfilled:
(i), DDD is manifested by morphologic changes of the nucleus; (ii), the annulus
fibrosus  must  be  competent;  (iii),  residual  disc  height  is  at  least  5  mm  [10].
Perhaps the most successful nucleus prosthesis is the PDN-Solo [11, 12],
developed by Raymedica Inc. (Minneapolis, USA). This implant has a hydrogel
core, which is packed in a woven polyethylene jacket.
We became interested in developing an alternative to the commercial PDN,
based on our previous work on radiopaque biomaterials and hydrogels[13, 14].
We hypothesized that the PDN concept can be improved further, especially
concerning radiovisibility, taking advantage of contemporary insights into new
polymeric biomaterials which combine several desirable properties (e.g. intrinsic
radiopacity, controllable swelling, controllable physical-mechanical properties)
[15]. We reasoned that it should be possible to design and fabricate a synthetic
nucleus prosthesis that meets the following requirements:
The prosthesis consists of a hydrogel that, like the healthy nucleus, but unlike
the PDN, fills up the entire cavity that is enclosed by the annulus ring.
The prosthesis is implanted in dry form (xerogel), allowing the opening in the
annulus to be small. After insertion, the implant is allowed to swell (expand) in
situ.
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The prosthesis has excellent visibility through both X-ray fluoroscopy and
magnetic resonance imaging (MRI), such that no artifacts occur.
The swollen hydrogel has adequate physical-mechanical properties and fatigue
resistance. For instance, the prosthesis must resist continuous loading, and
peak loading which occurs upon bending or lifting things[16, 17].
Herein, we report on two different hydrogel biomaterials that potentially fulfill
the above criteria. The envisioned procedure is depicted schematically in Figure
1. Filling the entire cavity, evidently, makes the new implants more biomimetic
as compared to the PDN.
Figure 1: Schematic representation of nucleus replacement using a hydrogel:
step 1 involves complete removal of the affected nucleus, step 2 is the insertion
of the xerogel in the cavity, through a minimal incision in the annulus and step
3 is the subsequent in situ swelling to reach situation 4, in which the synthetic
nucleus mimics the natural healthy situation.
Using both materials, nucleus prostheses prototypes were designed,
manufactured and studied. We describe a series of experiments that reveal (i)
biocompatibility in an in vivo model, (ii) implantability and in situ swelling, and
(iii) visibility of the implant through X-ray and MR imaging. Moreover, the steps
to take before the prosthesis can be introduced clinically are discussed briefly.
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2 Materials and methods
2.1 Hydrogels
Two hydrogels were prepared by copolymerizing either N-vinyl-2-pyrrolidinone
(NVP) or 2-hydroxyethyl methacrylate (HEMA) with the radiopaque monomer 2-
(4’-iodobenzoyl)-oxo-ethyl methacrylate (4IEMA) [18, 19] in the molar ratio 94 :
6. We used 6 mol% 4IEMA to slightly increase the radiopacity compared to the
conclusions in previous work, wherein 5 mol% 4IEMA was selected [15]. NVP
and HEMA were purchased from Acros and distilled under reduced pressure
before use. The monomer mixtures, together with 0.044 mol% of 2,2’-
azobis(isobutyronitrile) (AIBN) were transferred to Teflon tubes. AIBN is the
source of free radicals. The Teflon tubes were immersed in a temperature
controlled oil bath. A temperature profile was run that keeps the oil bath for 8 h
at  60 °C,  followed by 4 h at  80 °C and another  4 h at  100 °C.  The resulting
copolymers are indicated by N94 (NVP / 4IEMA; 94/6) and H94 (HEMA / 4IEMA;
94/6). For both materials, the equilibrium water content (EWC) and volume
swelling ratio (VSR) were determined in a swelling experiment in phosphate
buffered saline (PBS) at room temperature. For this, the mass and dimensions
of discs of the materials were monitored at various intervals, until equilibrium
was  reached.  The  VSR  is  the  swollen  volume  divided  by  the  dry  volume  and
EWC is  defined as the weight  percentage of  water  in  the swollen hydrogel  at
equilibrium. The Young’s modulus of swollen cylindrical samples (9 mm
diameter,  9  mm  height,  after  equilibrium  swelling)  of  both  hydrogels  was
determined from the initial slope of the stress-strain curve, measured in
compression (strain rate 3 × 10-3 s-1)  using a Zwick 1445 compression bench
with  a  500N  load  cell  in  a  water  bath,  which  was  kept  at  a  constant
temperature (37°C).
2.2 Biocompatibility in vivo
The animal experiments were reviewed and approved by the Animal Ethical
Committee of the University of Maastricht.
Dry copolymer discs  of  both N94 and H94 were sterilized with ethylene oxide
and swollen in sterile PBS before implantation. Eight FVB mice of approximately
11 weeks old were anesthetized and operated under sterile conditions.
Subcutaneous  pockets  were  created  on  the  back  and  in  each  pocket  one
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swollen  hydrogel  disc  of  both  N94  and  H94  (4  mm  diameter  and  1  mm
thickness) was implanted to study the tissue reaction to the materials. Ethanol-
sterilized PMMA discs of the same dimensions were used for comparison; PMMA
is a proven biomaterial. Hence, each mouse received 3 implants.
Four mice were sacrificed after one week, the others after 3 months. At 5
weeks, X-ray images were taken of the remaining four mice. After sacrificing
the mice, the materials and some of the surrounding tissue were removed and
fixated in buffered formalin. Then the retrieved implants were dehydrated using
a graded alcohol series and embedded in glycol methacrylate (Technovit 7100;
Heraeus Kulzer, Germany). Subsequently the embedded specimens were
sectioned (3 ?m) and stained with haematoxylin-eosin (HE). The histology was
evaluated using light microscopy.
2.3 Porcine intervertebral disc
A lumbar spinal section was explanted from a recently deceased adult male pig.
It  was  cleaned  from soft  tissues  and  conserved  at  -80°C.  For  implantation  of
the hydrogel, a disc was isolated by sawing adjacent vertebrae in their middle.
After sawing, the spinal segment was allowed to thaw overnight. The size and
shape of the porcine lumbar nucleus cavity was adapted from several cadaver
specimens. The xerogels were machined to this shape, and their size was
diminished to incorporate their swelling ability, so that their size after swelling
matches the cavity size. Clinically, MRI can be employed to determine nucleus
dimensions of the affected intervertebral disc in a patient, through
discriminating annulus and nucleus by their water content (T2-relaxation),
enabling the selection of an implant with the exact shape and size.
2.4 Hydrogel implantation
The annulus of the isolated disc was cut using a surgical blade posterolateral.
Two parallel incisions were made and one perpendicular incision, between the
two incisions.  This  is  to  create a flap from the outer  annulus layers.  The flap
was pulled away and a midannular incision was made through the annulus to
reach the nucleus cavity (Figure 2). The gelly nuclear material was removed as
much as possible with a small scoop. A prosthesis made from N94 was inserted
using forceps. Care was taken to insert the xerogel properly into the nucleus
cavity. Next, some PBS was injected into the cavity to initiate hydration of the
implant. The annulus flap was sutured to close the defect. Then the entire
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segment  was  submerged  in  PBS  and  the  implant  was  allowed  to  swell
overnight.
Figure 2: The annulus incision created to insert the nucleus prosthesis. After
implantation the flap in the annulus is closed with suture.
2.5 Visualization
To investigate the position of the swollen hydrogel inside the nucleus cavity, CT
and MRI scans were made. CT scans of the hydrogel had to prove if the X-ray
contrast is sufficient after swelling, since the iodine concentration is lowered
after  swelling.  Due to the high water  content,  the implant  can also be clearly
visualized using a T2-weighted MRI sequence. After the scans, the disc was
carefully sectioned through the annulus fibrosus to reveal the swollen implant
and photographs were taken.
3 Results and discussion
3.1 Hydrogels
Thermal radical polymerization of the monomer mixtures resulted in clear glassy
polymers. The resulting copolymers (N94 and H94) were washed prior to
further analysis to get rid of any possible unreacted monomer.
The  swelling  ability  of  N94  is  greater  than  H94,  because  NVP  is  more
hydrophilic than HEMA. This can be expressed in terms of VSR or EWC (Table
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1). The EWC was determined at room temperature, but the difference in water
content between room and body temperature is minimal (<1%). The Young’s
modulus as determined in a compression experiment is also shown in Table 1.
Mark that, though both hydrogels have quite different water contents, their
moduli are almost equal. The Young’s modulus is a measure for the material’s
stiffness,  and for  this  application it  is  necessary to  be in  the range of  0.2 – 4
MPa in order to mimic the mechanical behaviour of the natural nucleus
pulposus[9, 20-22].
Table 1: Material properties.
Material VSRa (v/v) EWCb (m/m) Young’s modulus
N94 3.9 74% 0.7 Mpa
H94 1.5 23% 0.9 MPa
a VSR: volume swelling rate. b EWC: equilibrium water content.
3.2 In vivo biocompatibility
Macroscopic observations
The  wound-healing  process  of  the  mice  appeared  to  be  normal  and  the
implants could be observed as small bumps on the back. On the X-ray images
both N94 and H94 can be distinguished (Figure 3), N94 at a slightly tilted angle.
After retrieval of the implants, no changes in visual appearance or dimensions
were observed after 3 months. Obviously, for these materials to serve as
permanent nucleus prostheses, degradation is unacceptable.
Figure 3: X-ray of the subcutaneously implanted hydrogel discs in a mouse.
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Histology
The one week follow-up of the subcutaneous implantation in mice showed mild
acute inflammatory reactions and the start of a fibrous capsule for all materials.
After 3 months, a thin fibrous capsule was present around all implants,
containing linearly organized fibroblasts, aligned parallel to the implants. Figure
4 shows representative light micrographs of the materials after 3 months of
subcutaneous implantation. The capsule thickness was comparable for all
implants (±40?m). A minimal inflammatory reaction was observed containing
some macrophages and granulocytes and some newly formed blood vessels.
Because PMMA is very stiff as compared to the surrounding embedded tissue,
the fibrous capsule gets somewhat compressed during the cutting procedure.
Basically, all 3 materials triggered only minimal and comparable tissue
reactions. So both our swollen hydrogel materials N94 and H94 perform equally
biocompatible as the proven hydrophobic biomaterial PMMA. The histological
data of N94 and H94 are comparable to the results that were obtained
previously by Aldenhoff et al., who studied long-term biocompatibility of
analogous, but non-swelling radiopaque biomaterials [23].
Figure 4: HE-staining of sections of the retrieved implants after 3 months. The
materials are in the top of the image and a piece of the dermis (d) is seen
underneath. Around all implants a thin fibrous capsule (fc) can be observed and
some inflammatory cells (arrows) are present. The scale bars represent 50?m.
3.3 Porcine intervertebral disc
The porcine nucleus is kidney-shaped with the dimensions: 25×13×4.5 mm
(l×w×t).  To  incorporate  the  swelling  ability  of  N94  the  dimensions  of  the
implant were 15.5×8×2.8 mm (Figure 5). The time needed for this implant to
reach equilibrium swelling is about one day. Once swollen, this implant will
completely fill the cavity, left after removal of the gelly nucleus material. This is
expected  to  result  in  optimal  transmission  of  compressive  forces  onto  the
annulus fibers, thus mimicking the physiological state [20].
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Figure 5: The swollen and dry hydrogel nucleus prosthesis. The shape is
conforming to the porcine nucleus cavity.
3.4 Hydrogel implantation
Flap generation in the annulus fibrosus and aspiration of the natural nucleus
pulposus proceeded smoothly. The nucleus prosthesis was inserted readily
using a pair of tweezers, through the incision in the annulus fibrosus. Evidently,
it must be inserted to align the curvature of the cavity. Through swelling
pressure, the implant will probably position itself correctly within the empty
nucleus cavity, since this is an unloaded situation. After implantation, PBS was
injected  into  the  cavity  and  the  flap  was  sutured  to  close  the  annular  defect.
The implant will swell in situ to almost 4 times its original volume. This makes
the implant much larger than the incision that was created in the annulus to
implant the dry prosthesis and therefore extrusion is expected to be impeded.
3.5 Visualization
After  one  day,  the  swelling  of  an  implant  of  the  material  N94  with  the
dimensions of the nucleus cavity is complete. CT and MRI scans were made of
the porcine vertebrae containing the nucleus prosthesis. The CT and MRI image
are shown in Figures 6A and 6B respectively. Both techniques can clearly
distinguish the implant in the nucleus cavity. Apparently, the X-ray contrast of
the swollen hydrogel is sufficient to visualize it in between two vertebrae.
During  surgery,  X-ray  fluoroscopy  will  probably  be  used  instead  of  CT,  but  in
terms of X-ray contrast there is no difference. Earlier, it was seen that these
types of material can be visualized in situ using  X-ray  fluoroscopy  [15].  CT
provides extra information, since it is 3-dimensional. Also, due to the high water
content, it can be clearly seen on the MRI image. An implant made out of H94
has a much lower water content, but will probably also appear on a MRI image:
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the difference in water content and subsequent T2-relaxation, between annulus
and prosthesis, provides the contrast. On the contrary, due to its lower water
content, H94 will exhibit more contrast using X-rays.
Figure 6: Visualization  of  the  hydrogel  implant,  using  (A)  CT  and  (B)  T2-
weighted MRI. Both techniques clearly show the correctly positioned hydrogel
implant.
Then, the intervertebral disc was sectioned to reveal the swollen hydrogel
within the nucleus cavity (Figure 7). It confirmed the imaging techniques; the
swollen implant completely filled the nucleus cavity.
Figure 7: Picture of the swollen implant in the nucleus cavity; it perfectly fills
the entire cavity.
4 Concluding Remarks
It is a challenge to design a radiopaque hydrogel that can withstand the harsh
environment of the spinal column. Both radiopaque hydrogels, N94 and H94,
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fulfill a set of requirements to serve as prosthetic biomaterials for replacement
of the nucleus pulposus. In particular, they offer the clinically significant
advantage of integral visibility through  CT  and  MRI.  The  absence  of  any
artifacts in the MRI images is believed to be important, especially in view of the
fact that there is a trend towards higher magnetic field strengths; these lead to
improved quality of the MR images, but also to amplification of artifacts, such
as those caused by metallic X-ray markers.
Moreover, it was verified that implants of N94 and H94 can be introduced into
the nucleus cavity through a so-called annulus flap; this is an established
technique in spinal surgery. N94 has a larger swelling capacity as compared to
H94, which is theoretically beneficial. Still, extensive biomechanical tests will be
performed in the near future, especially since implant extrusion and fatigue
behaviour are important issues in this field. Preliminary fatigue tests seem
promising.  With  our  novel  method  we  may  decrease  the  risk  of  implant
extrusion due to the improved and customized implant fit. Further experiments
are planned to explore which material performs best in vivo. Biocompatibility of
N94 and H94 was tested in an animal model (subcutaneous implantation for 3
months). Both materials were well tolerated, there were no signs of severe
adverse tissue reactions. Histology of the tissues surrounding N94 and H94
were comparable to the histology of the tissues around the control material
PMMA.
The results of this study provide further support for our earlier hypothesis, that
these radiopaque hydrogels hold promise as improved biomaterials to replace a
diseased or damaged nucleus pulposus in cases of a competent annulus
fibrosus[15]. It is clear that more research is mandatory before clinical
application of the new radiopaque hydrogels is possible. The nucleus prosthesis
is  a  surgically  invasive  implant  for  long  term use  (>30  days),  which  falls  into
Class IIb of the EC Medical Device Directive[24]. First, physical-mechanical
testing for durability is necessary (fatigue resistance preferably in a confined
model[25] and creep behaviour). Secondly, tests of the implant in a
representative animal model need to be executed[26-29]. Thirdly, provided that
the  outcome  of  all  experiments  is  positive,  a  clinical  pilot  study  needs  to  be
done. Then, the combined experimental data need to be examined by one of
the  Notified  Bodies,  which  can  then  award  the  CE  mark.  It  is  important  to
consider that the two new radiopaque hydrogels are non-classical biomaterials,
especially since 4IEMA was used as one of the building blocks. Another implant,
the so-called ScrewFinder[30], which is also based on 4IEMA, already received
a CE mark in 2001 (2012476CE01).
Evaluation of Intrinsically Radiopaque Hydrogels for Replacing the Nucleus Pulposus | 67
Acknowledgements
This research was funded by the Dutch Polymer Institute (DPI), project number
398, Intervertebral Disc Prosthesis.
References
1. Ghiselli  G,  Wang  JC,  Bhatia  NN,  Hsu  WK,  Dawson  EG.  Adjacent  segment
degeneration in the lumbar spine. J Bone Joint Surg Am 2004; 86-A: 1497-1503.
2. Phillips FM, Reuben J, Wetzel FT. Intervertebral disc degeneration adjacent to a
lumbar fusion. An experimental rabbit model. J Bone Joint Surg Br 2002; 84: 289-
294.
3. Hilibrand AS, Robbins M. Adjacent segment degeneration and adjacent segment
disease: the consequences of spinal fusion? Spine J 2004; 4: 190S-194S.
4. Bao QB, McCullen GM, Higham PA, Dumbleton JH, Yuan HA. The artificial disc:
theory, design and materials. Biomaterials 1996; 17: 1157-1167.
5. Gillet P. The fate of the adjacent motion segments after lumbar fusion. J Spinal
Disord Tech 2003; 16: 338-345.
6. Bao QB, Yuan HA. New technologies in spine: nucleus replacement. Spine 2002;
27: 1245-1247.
7. Ray CD. The PDN prosthetic disc-nucleus device. Eur Spine J 2002; 11 Suppl 2:
S137-142.
8. Husson JL, Korge A, Polard JL, Nydegger T, Kneubuhler S, Mayer HM. A memory
coiling spiral as nucleus pulposus prosthesis: concept, specifications, bench
testing, and first clinical results. J Spinal Disord Tech 2003; 16: 405-411.
9. Thomas  J,  Lowman  A,  Marcolongo  M.  Novel  associated  hydrogels  for  nucleus
pulposus replacement. J Biomed Mater Res 2003; 67A: 1329-1337.
10. Guyer RD, Ohnmeiss DD. Intervertebral disc prostheses. Spine 2003; 28: S15-23.
11. Jin D, Qu D, Zhao L, Chen J, Jiang J. Prosthetic disc nucleus (PDN) replacement
for lumbar disc herniation: preliminary report with six months' follow-up. J Spinal
Disord Tech 2003; 16: 331-337.
12.  Carl  A,  Ledet  E,  Yuan  H,  Sharan  A.  New  developments  in  nucleus  pulposus
replacement technology. Spine J 2004; 4: 325S-329S.
13. van Hooy-Corstjens CSJ, Govaert LE, Spoelstra AB, Bulstra SK, Wetzels GM, Koole
LH. Mechanical behaviour of a new acrylic radiopaque iodine-containing bone
cement. Biomaterials 2004; 25: 2657-2667.
14. Peerlings CC, Hanssen HH, Bevers RT, Boelen EJH, Stelt BJ, Korthagen EJ, Koole
LH. Heparin release from slippery-when-wet guide wires for intravascular use. J
Biomed Mater Res 2002; 63: 692-698.
68 | Chapter 3
15. Boelen EJ,  van Hooy-Corstjens CS, Bulstra SK, van Ooij  A,  van Rhijn LW, Koole
LH. Intrinsically radiopaque hydrogels for nucleus pulposus replacement.
Biomaterials 2005; 26: 6674-6683.
16. Ghosh P (ed.). The biology of the intervertebral disc. vol. 1. CRC Press; 1988.
17. White AA, Panjabi MM. Clinical biomechanics of the spine. Philadelphia:
Lippincott; 1978.
18.  Kruft  MA,  Benzina  A,  Blezer  R,  Koole  LH.  Studies  on  radio-opaque  polymeric
biomaterials with potential applications to endovascular prostheses. Biomaterials
1996; 17: 1803-1812.
19.  van  Hooy-Corstjens  CSJ,  Aldenhoff  YB,  Knetsch  ML,  Govaert  LE,  Arin  E,  Erli  H,
Koole  LH.  Radiopaque  polymeric  spinal  cages:  a  prototype  study.  Journal  of
Materials Chemistry 2004; 14: 3008-3013.
20. Meakin JR, Reid JE, Hukins DW. Replacing the nucleus pulposus of the
intervertebral disc. Clin Biomech (Bristol, Avon) 2001; 16: 560-565.
21. Fagan MJ, Julian S, Siddall DJ, Mohsen AM. Patient-specific spine models. Part 1:
Finite element analysis of the lumbar intervertebral disc--a material sensitivity
study. Proc Inst Mech Eng [H] 2002; 216: 299-314.
22. Meakin JR. Replacing the nucleus pulposus of the intervertebral disk: prediction
of suitable properties of a replacement material using finite element analysis. J
Mater Sci Mater Med 2001; 12: 207-213.
23. Aldenhoff YB, Kruft MAB, Pijpers AP, van der Veen FH, Bulstra SK, Kuijer R, Koole
LH. Stability of radiopaque iodine-containing biomaterials. Biomaterials 2002; 23:
881-886.
24. Medical Devices Directive.
http://europa.eu.int/comm/enterprise/medical_devices/meddev/
25. Joshi A, Fussell G, Thomas J, Hsuan A, Lowman A, Karduna A, Vresilovic E,
Marcolongo M. Functional compressive mechanics of a PVA/PVP nucleus pulposus
replacement. Biomaterials 2006; 27: 176-184.
26. Wilke HJ, Kettler A, Claes LE. Are sheep spines a valid biomechanical model for
human spines? Spine 1997; 22: 2365-2374.
27. Smit TH. The use of a quadruped as an in vivo model for the study of the spine -
biomechanical considerations. Eur Spine J 2002; 11: 137-144.
28. Reid JE, Meakin JR, Robins SP, Skakle JM, Hukins DW. Sheep lumbar
intervertebral discs as models for human discs. Clin Biomech (Bristol, Avon) 2002;
17: 312-314.
29.  Schimandle  JH,  Boden  SD.  Spine  update.  Animal  use  in  spinal  research.  Spine
1994; 19: 2474-2477.
30.  Bulstra  SK,  Benzina  A,  Kuijer  R,  Koole  LH.  Novel  screw  caps  for  use  in
orthopaedic and trauma surgery. Med Device Technol 1999; 10: 38-39.
4
Towards a Functional Radiopaque Hydrogel
for Nucleus Pulposus Replacement
Erik J.H. Boelen, Catharina S.J. van Hooy-Corstjens, Lodewijk W. van Rhijn and
Leo H. Koole
Adapted from:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials. In press
70 | Chapter 4
Abstract
Patients with severe back pain, attributed to a herniation of the nucleus
pulposus of the intervertebral disc, can benefit from a replacement of only the
nucleus pulposus, provided the annulus fibrosus is still functional. This study
investigated four intrinsically radiopaque hydrogel biomaterials, which were
designed specifically to replace the herniated nucleus pulposus. The important
characteristic of these hydrogels is that they can be visualized entirely with both
MRI  and  X-rays.  The  materials  are  based  on  copolymers  of  N-vinyl-2-
pyrrolidinone (NVP) and/or 2-hydroxyethyl methacrylate (HEMA) and a
radiopacity introducing monomer, 2-(4’-iodobenzoyl)-oxo-ethyl methacrylate
(4IEMA).  Two  of  the  formulations  also  contain  the  chemical  crosslinker  allyl
methacrylate (AMA). Physical-mechanical properties like the water-uptake,
biocompatibility, stiffness, and fatigue and creep behaviour were studied, whilst
keeping an eye on the intended application. All four materials were designed
with  5-6  mass% of  iodine  to  ensure  sufficient  X-ray  visibility  in  between  two
vertebrae. It was found that the materials display appropriate stiffness and
biocompatibility. The crosslinked materials hold most promise as a functional
nucleus prosthesis, as they combine these properties also with high water
content, fatigue resistance, and recovery after loading.
Towards a Functional Radiopaque Hydrogel for Nucleus Pulposus Replacement | 71
1 Introduction
Debilitating  low  back  pain  is  an  immense  problem  [1],  with  a  myriad  of
pathologies. Very often, the actual cause is unknown [2], despite extensive
investigations even with modern imaging techniques [3]. In cases where a
specific  diagnosis  can  be  made,  the  pain  can  often  be  attributed  to  an
intervertebral disc problem. Treatment of such patients is usually conservative
(i.e., through exercise or physiotherapy). In severe cases however, surgery may
be inevitable. When the patient suffers from Hernia Nucleus Pulposus (HNP)
and the annulus fibrosus is still  competent, except for the herniated part, it is
sufficient to merely replace the nucleus pulposus [4, 5]. HNP usually occurs at
the lumbar level of the spine. Also in cases of early degenerative disc disease
(DDD), replacing the nucleus pulposus can be an option. Nucleus replacement
is an emerging approach. It preserves the remaining disc structures, i.e. the
annulus fibrosus and the endplates, provided they are still functional.
Indications and contraindications are very important to consider [6] and the
decision for a nucleus replacement is left to the discretion of the surgeon.
Several designs already exist to serve as a nucleus replacement, using a variety
of approaches [7-13]. Previously, we have advocated that improved prostheses
for the nucleus pulposus can be made on the basis of radiopaque biocompatible
hydrogels with intrinsic radiopacity [14, 15]. These should be designed and
shaped in such a way that they completely fill (after swelling) the cavity that is
confined by the annulus fibrosus and the upper and lower endplates. Two
promising radiopaque hydrogels emerged from our previous work: (i), the
copolymer of N-vinyl-2-pyrrolidinone (NVP) and 2-(4’-iodobenzoyl)-oxo-ethyl
methacrylate  (4IEMA) with molar  ratio  NVP :  4IEMA = 94 :  6,  this  material  is
abbreviated as N94; (ii), the copolymer of 2-hydroxyethyl methacrylate (HEMA)
and 4IEMA with molar ratio HEMA : 4IEMA = 94 : 6, this material is abbreviated
as H94 [15]. Both materials were implantable, and they featured excellent
biocompatibility and radiopacity.
To date, no official test methodologies have been specified for nucleus pulposus
replacements [16]. Here, we focus specifically on the stiffness, creep behaviour
and recovery of N94 and H94. Furthermore, we slightly adapted both
compositions  to  overcome  two  residual  drawbacks  of  both  materials:  (i)  NVP
and NVP-oligomer leaching from N94 during swelling, directly after synthesis,
and (ii) limited swelling and water uptake of H94. Both goals were achieved
through the use of the crosslinker allyl methacrylate (AMA).
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We describe two new radiopaque hydrogel biomaterials which are believed to
be optimal for the intended application as a nucleus pulposus prosthesis at the
lumbar level: the crosslinked version of N94, and a crosslinked terpolymer of
NVP, HEMA and 4IEMA. Physical-mechanical properties of these novel
biomaterials, i.e., water diffusion, swelling, stiffness, fatigue resistance, and
recovery,  as  well  as  the  results  from  biocompatibility  assays in vitro, are
described.
2 Materials and methods
2.1 Materials
All chemicals were purchased from Acros (Landsmeer, The Netherlands). Both
NVP and HEMA were distilled under reduced pressure to remove inhibiting
additives. The monomer 4IEMA was synthesized as described before [17]. The
crosslinker allyl methacrylate (AMA) was used as received, and 2,2’-
azobis(isobutyronitrile) (AIBN) was used as the source of free radicals in the
temperature controlled bulk polymerization. Monomers and 0.03 mol% of AIBN
were mixed and transferred to Teflon tubes, which were closed with a stopper
on  one  end.  Then  they  were  immersed  in  a  thermostated  oil  bath  and  the
temperature profile as depicted in Figure 1 was run. Four different materials
were prepared as indicated in Table 1. The polymerization yielded transparent,
glassy rods, which were machined to discs or cylinders for the different
analysis. All resulting polymers contain 5-6 mass% iodine, which was found to
be sufficient for visualizing the resulting hydrogels in between two vertebrae
[14].
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Figure 1: Temperature profile of the oil bath used for the radical
polymerization.
Table 1: Material composition in molar percentages.
Material NVP HEMA 4IEMA AMA
N94 94 - 6 -
H94 - 94 6 -
N94_2 92.1 - 5.9 2
T94_2 71.8 20.4 5.8 2
2.2 Swelling and diffusion
Swelling of the different materials was studied by placing three discs of each
material (n=3) in ample phosphate-buffered saline (PBS) (37 ºC) and weighing
them frequently at different time intervals, after removing the surface water
with a tissue. The aspect ratio of the discs (diameter/thickness) was more than
10, so one-dimensional penetrant diffusion could be assumed [18]. The water
content is defined as the mass percentage of water in the swollen disc. It was
noted that  the mass increase already levelled to  a  plateau value after  3  h.  It
could not be excluded however, that some release of low-molecular mass
extractables  occurs  at  this  stage  [14];  we  assumed  that  full  equilibration  is
achieved after 2 weeks. Therefore, the equilibrium water content (EWC), as
well as the volume swelling ratio (Q) of every material was determined after 2
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weeks of incubation. After 2 weeks the materials were weighed once more and
their dimensions were measured. Subsequently, the discs were dried. The
equilibrium water content (EWC) was calculated, using the material masses
after  2  weeks  of  swelling  and  the  dried  mass.  The  volume  swelling  Q  was
determined by dividing the swollen volume by the dried volume. However, all
samples were somewhat curved after drying, so sometimes it proved difficult to
obtain true dimensions.
2.3 Cell viability
To evaluate the cytotoxicity of the materials, three dried, prewashed discs were
UV-sterilized and swollen in medium for 2 days. Then, 3T3 mouse fibroblasts
were placed on the surface of the hydrogel discs (104 cells/cm2, day 1). At day
2, the medium was refreshed and at day 3 the adhering cells were evaluated
using the Live/Dead assay (Molecular Probes, Viability/Cytotoxicity Kit (L-3224))
by fluorescence microscopy (Nikon Eclipse E800 equipped with a Coolsnap
camera (RS Photometric, USA)) [19].
2.4 Static mechanics
In order to determine basic mechanical properties of the materials, cylindrical
samples (15 mm diameter, 15 mm height), swollen to equilibrium in water,
were compressed to failure at a strain rate of 3 × 10-3 s-1.  Compression  was
performed in a waterbath at 37 ºC, on a Zwick 1445 tension-compression tester
using a 500 N load cell (n ? 3). The Young’s modulus was determined from the
linear slope of the resulting compression curves (up to 8% compressive strain).
2.5 Dynamic mechanical analysis
Swollen, cylindrical samples (15 mm diameter, 15 mm height) of the materials
were subjected to a sinusoidal loading profile at several frequencies in the
range 0.1 to 5 Hz (n ? 3). The mean compression level was 1.5 mm and the
amplitude was 0.5 mm. Hence, compressive strain was within the region of
linear elasticity (<15%). The tests were preformed on a MTS 810 Elastomer
Test  System,  equipped  with  a  2.5  kN  load  cell,  in  a  37  ºC  water  bath  and
yielded the complex modulus E* and phase angle ?.
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2.6 Rheology
For rheological characterization of the hydrogels, thin discs (2 mm), swollen to
equilibrium, were used with an aspect ratio larger than 10. The experiments
were preformed on a parallel plate viscometer (ARES 3LSLC1, Rheometric
Scientific)  at  37 ºC (n = 3).  The material  was compressed axially  between to
parallel  plates  to  0.18  N  and  PBS  was  applied  around  the  edge  to  prevent
dehydration.  Also  a  small  hood  was  placed  over  the  setup.  At  first  a  strain
sweep (0.005% - 0.5%) was performed at an angular frequency of 10 rad/s. It
was concluded that 0.01% strain was within the region of linear elasticity, so a
dynamic  frequency  sweep  was  performed  at  this  strain  from  1  –  100  rad/s
(n=3), to yield material data like complex shear modulus G* and phase angle ?.
2.7 Creep and fatigue
The creep experiments were performed on the same system as the static
mechanical tests. The samples were compressed to 0.1 MPa engineering stress
for 3 h, followed by a force of 0 N for 1 h, to monitor their recovery. Sample
heights before and after the tests were measured using a digital calliper. The
compression was chosen to be 0.1 MPa, which is the physiologic swelling
pressure of the intervertebral disc [20, 21].
Fatigue resistance was checked using the same test system as for the DMA, but
with  a  25  kN  load  cell  this  time.  At  a  frequency  of  5  Hz  it  was  verified  if
cylindrical samples of the swollen material survive 106 cycles of compression
from 0.1 MPa engineering stress to 15% strain (n = 3). One million cycles was
chosen as a preliminary indication of fatigue resistance. To keep contact
between the sample and the indenter, the test was preformed force controlled.
Therefore, before starting the experiment, the indenter was lowered to 15%
compression and the force needed was recorded. This force was then used as
upper limit.
2.8 Statistical analysis
The results of the hydrogel properties were statistically analyzed using one-way
ANOVA, with the Bonferroni correction, with a value of p <  0.05  taken  to  be
significant.
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3 Results
3.1 Swelling and diffusion
The water  uptake of  the materials  in  37 ºC PBS was meticulously  followed in
time. The masses of the discs were measured regularly. The water content as a
function of time is plotted in Figure 2. The materials swell isotropically. The
difference  in  water  content  of  the  materials  in  water  versus  PBS  at  37  ºC,  is
smaller than 1%.
Figure 2: Swelling  curves  of  the  polymers  in  PBS  at  37  ºC  as  a  function  of
time.
Figure 2 shows that water uptake is relatively fast for the NVP-based materials
N94 and N94_2: a plateau level is reached within 2 h of incubation. Swelling of
the HEMA-based hydrogels is somewhat slower; a plateau is reached after 3 h.
As expected, the NVP-based hydrogels absorb more water in comparison with
the HEMA-based materials. The data in Figure 2 were used to calculate several
parameters that characterize the diffusion process for each of the materials: (i)
the diffusional exponent (n), and (ii) the diffusion coefficient (D). The values for
n were calculated with the formula:
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where Mt and M? are  the  mass  of  water  in  the  sample  at  time t and at
equilibrium hydration respectively, k is a constant and n is the diffusional
exponent.  The  swelling  data  were  fitted  to  equation  1  and  the  diffusional
exponent n was  deduced  from the  initial  part  (Mt/M? < 0.6) of the resulting
graph (Table 2). From the values for n can  be  concluded  that  the  uptake  of
water is mainly diffusion controlled (n?0.5). Now, the diffusion coefficient D
can  be  calculated  from  the  short  time  approximation  of  Fick’s  law  for  thin
sheets [22, 23],
5.0
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where l is  the  initial  thickness  of  the  sheet.  Table  2  shows  the  diffusion
coefficient D for the different materials. These data reflect, on a quantitative
basis, that water uptake is fastest for the NVP-based hydrogels.
After 2 weeks in PBS (37 ºC), the materials were weighed and measured once
more and dried. From this, the EWC, volume swelling Q and mass loss of the
different materials are determined (Table 2). The data are all significantly
different.
Several  conclusions  can  be  drawn  from  this  data:  (i)  material  N94  loses  a
substantial  amount  of  extractables  during  the  2  weeks  of  incubation,  as  is
evident  from  its  mass  loss  (40.2%).  This  is  a  serious  disadvantage,  which
disqualifies N94 for the intended use as a prosthesis for the nucleus pulposus.
(ii) Material H94 does not show any mass loss during incubation. In part, this
observation is not surprising, since it is know that free radical polymerization of
HEMA leads to the formation of three dimensional crosslinked networks. The
existence of such a network could also explain why the EWC of H94 is relatively
low (22.4%): swelling requires the expansion of the 3D network, which
becomes progressively more difficult as the network density increases.
Moreover, (co)polymers of HEMA are known to be less hydrophilic than
(co)polymers derived from NVP. With respect to the intended application, it can
be concluded that H94 is not suitable, since swelling is insufficient. (iii) Material
N94_2 overcomes much of the principal drawback of N94, in the sense that the
loss  of  mass  via  extractables  is  reduced  substantially,  i.e.  from approximately
40%  to  approximately  12%.  This  effect  is  solely  due  to  crosslinking.
Interestingly,  the  EWC  of  N94_2  is  still  high  (55%).  With  respect  to  the
application, the loss of 12% of the mass during swelling is still  a drawback, in
view  of  the  toxic  effect  that  such  extractables  inflict.  Application  of  N94_2
78 | Chapter 4
would only be possible after a pre-wash step. (iv) The terpolymer T94_2
represents a further improvement of N94_2, in terms of further reduction of the
mass loss, while the EWC is still relatively large. Note that T94_2 still loses
some  extractables  during  the  2  weeks  of  incubation,  approximately  2%.  This
might still imply that a pre-wash step is required to avoid any toxic reaction.
Table 2: Data determined from the swelling experiment in PBS at 37 ºC.
Material
EWC
(wt.%)
Q
Mass loss
(wt.%)
n
D ×  105
(cm2 min-1)
N94 73.5 ± 0.1 3.7* 40.2 0.55 2.9
H94 22.4 ± 0.6 1.4 0 0.51 0.7
N94_2 55.0 ± 0.1 2.1 11.8 0.48 3.2
T94_2 46.1 ± 0.1 2.0 2.3 0.47 2.0
* Due to the curving of the material, the diameter could not be accurately
measured.
3.2 Cell viability
Figure 3 shows micrographs, obtained with the Live/Dead assay. The surfaces
contain mostly live cells (green) and sporadically a dead cell (red). Although
cells prefer more hydrophobic surfaces [24], some cell spreading on the surface
can be observed. Only the new, crosslinked materials were evaluated, since the
biocompatibility of N94 and H94 was already demonstrated in vivo in a mouse
model, by subcutaneous implantation [15]. The addition of the crosslinker AMA
to the material  (N94_2),  or  the crosslinked combination of  both N94 and H94
(T94_2), does not show any adverse effects on the cytocompatibility and is not
expected to have ill effects on the biocompatibility. The intervertebral disc is the
largest avascular structure in the body [25], and the cell density in the nucleus
pulposus is low [26]. Nonetheless, for a nucleus replacement, cytocompatibility
is very important, also in view of the fact that the delicate spinal cord is in the
proximity of the implant.
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Figure 3: Micrographs obtained with fluorescence microscopy in the Live/Dead
staining  assay  of  3T3  mouse  fibroblast  cells  directly  on  the  surface  of  the
hydrogels.
3.3 Static mechanics
Figure 4 shows some typical compression curves of the materials. True stress is
plotted versus the strain. The materials behaviour for all materials, except N94,
is linear to at least 30%, which is twice the physiologic compression of the
intervertebral disc [21]. N94 shows non-linear behaviour beyond 12%
compression. Since, the physiologic compression is 15%, it is mandatory that
the materials behave linearly at least up to this strain, so no permanent
deformation occurs. Also, from the reported stiffness of the lumbar
intervertebral disc (2000 N/mm) and the maximal force (8 kN), a maximal
compression of 40% is expected [21, 27].
Figure 4: Stress-strain relationships obtained at a compressive strain rate of 3
× 10-3 s-1. For each material, a representative curve is shown (A). x indicates
material failure. Note in the expansion (B), the linearity for H94, N94_2 and
T94_2 up to 30% compression.
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All materials can be compressed to over 50%. H94 did not break, even at 80%
compressive strain. Table 3 shows the moduli, calculated from part of the linear
region  (up  to  8%)  in  the  compression  curves  and  the  strains  at  failure.  It  is
clear that crosslinking adds to the stiffness of the hydrogels at equilibrium.
Table 3: Stiffness and strain at failure of the hydrogels, when compressed at a
strain rate of 3×10-3 s-1 (37 ºC).
Material E (MPa)
Compressive strain
at failure (-)
N94 0.6 ± 0.1 0.69 ± 0.04
H94 0.8 ± 0.1 -
N94_2 1.5 ± 0.1 0.54 ± 0.06
T94_2 1.1 ± 0.1 0.58 ± 0.03
3.4 Dynamic Mechanical Analysis
Since the intervertebral disc is a very dynamic structure, it was also deemed
necessary to subject the materials to dynamic mechanical analysis (DMA).
From the dynamic sinusoidal loading profile, the complex modulus E* and the
phase angle ? were derived for several frequencies in the range 0.1 to 5 Hz. It
was noted that the materials behave stiffer when the frequency is higher; a
higher  strain  rate gave higher  moduli  (data not  shown).  Also the phase angle
increased slightly with increasing frequency, except for N94. The physiologic
frequency 1 Hz was of special interest. The values obtained at this frequency
for  E*  and  ? are  displayed  in  Table  4.  The  complex  moduli  correspond
qualitatively to the data on the Young’s moduli (Table 3), although the values of
E* are all slightly higher, which is caused by the higher strain rate.
Also displayed in Table 4 are values for the nucleus pulposus (NP) of sheep,
determined by Leahy et al. [28]. The sheep nucleus is very similar to the
human nucleus [29]. Clearly, our materials are much stiffer (compare E*
values). The phase angle (?=18 deg) corresponds with the ?-value of the
uncrosslinked materials N94 and H94, but is higher than the ?-values of N94_2
and T94_2. These crosslinked materials display a higher degree of elasticity, i.e.
they have a low phase angle, so they are expected to have better recovery
when subjected to loading.
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Table 4: Material parameters obtained at 1 Hz, using DMA and rheology.
DMA Rheology
Material
E* (MPa) ? (deg) G* (kPa) ? (deg)
N94 1.02 20.7 31.7 16.9
H94 1.19 17.6 63.5 19.9
N94_2 2.01 6.3 48.8 7.7
T94_2 1.48 6.3 80.8 6.0
NP 0.07# 18# 11$ 24$
# Data from Leahy et al.
$ Data from Iatridis et al.
3.5 Rheology
Material parameters that were derived from the rheological experiments are the
complex shear modulus G* and the phase angle ?. To compare with the data
obtained with DMA, the frequency was expressed in Hz instead of radians. The
complex shear modulus and phase angle are depicted in Figures 5A and 5B
respectively.  The values of  both G* and ? at  1  Hz are added to Table  4.  The
phase angles, measured using both techniques, are very comparable.
Rheological properties of the natural human nucleus pulposus at 10 rad/s (1.6
Hz) are also displayed in Table 4 (data from Iatridis et al. [30]).
All  of  our  materials  have  G*  values  that,  by  far,  exceed  G*  of  the  human
nucleus  pulposus  as  determined  by  Iatridis  [30,  31].  Figure  5  shows  that  G*
and ? of N94, N94_2 and T94_2 do not vary much as a function of frequency.
H94 on the other hand, clearly dissipates more energy upon increasing the
frequency, which is in agreement with previous work [14].
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Figure 5: Rheological spectra from a dynamic shear experiment at 0.01%
strain; (A) complex shear modulus G*, (B) phase angle ?.
3.6 Creep and fatigue
To  evaluate  the  ability  of  the  materials  to  resist  continuous  loading  and  their
recovery afterwards, a creep experiment was performed to an engineering
stress of 0.1 MPa [20], the basic physiologic stress the materials must be able
to withstand without permanent deformation. The tests were conducted without
radial constraint. The results are all significantly different and typical curves are
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depicted in Figure 6. Clearly, N94 displays a large creep effect, which causes it
to deform beyond linearity (see Figure 4). The creep effect in H94 is smaller
and this material recovers almost completely. The water content of H94 is low
and the material is also somewhat crosslinked, which explains its elastic
behaviour. Because of the significantly large creep effect of N94 and the low
EWC of H94, both materials were not included in the fatigue test. Very clear is
the  influence  of  the  crosslinker.  Both  N94_2  and  T94_2  hardly  show a  creep
effect and they both have practically no permanent deformation. The decrease
in height directly after the test was 0% for both N94_2 and T94_2, 1% for H94,
and 7% for N94. The recovery of the hydrogels is in accordance with the phase
angles given earlier. Those values already indicated that the crosslinked
materials behave more elastically.
The materials were compressed to 15% in the fatigue experiment. Both N94_2
and T94_2 survive the million cycles without any apparent deterioration. Since
the experiment was force controlled and radially unconstrained, the materials
were seen to lose some height gradually during the test. The cumulative effect
of  the  cyclic  loading  induces  creep  in  the  materials.  The  height  loss  was
significantly more pronounced in N94_2 (95.3% of height remaining), than in
T94_2 (97.5% of height remaining) at the end of the test.
Figure 6: Creep behaviour and recovery of the hydrogels subjected to 0.1 MPa
for 3 h.
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4. Discussion
Previous work on NVP/4IEMA copolymers revealed that leaching of NVP
oligomers occurs [14]. This is an indirect consequence of the difference in
reactivity of the monomers [32-34]. This reactivity difference causes 4IEMA to
polymerize preferentially in the beginning of the polymerization reaction, and
NVP towards the end, resulting in NVP oligomers. To reduce the amount of
extractables, a crosslinker was used that crosslinks vinyl to methacrylate
monomers. The commercially available monomer AMA has both an allyl group
and a methacryl group [35] and was found to be a suitable crosslinker for our
copolymers. After some trial experiments with different amounts of AMA, we
decided to use 2 mol% of AMA in the NVP/4IEMA copolymer, so N94 became
N94_2. Obviously, the introduction of the crosslinker AMA significantly reduces
mass loss, but also inevitably leads to a reduction in water content.
In analogy with the results of Lai et al. [35] we found that other crosslinkers,
such as divinylbenzene and triethyleneglycol methacrylate a.o., are less suitable
for crosslinking polymers based on NVP and methacrylates.
The material H94 does not show any mass loss in water, even without the
addition  of  a  chemical  crosslinker.  This  is  caused  by  physical  and  chemical
crosslinking within the material [36-38].
Terpolymers of NVP, HEMA and 4IEMA were investigated as well, in an effort to
combine the high water content of NVP-based copolymers with the elasticity of
the  HEMA-based  copolymers  in  equilibrium  with  water  at  37  ºC.  The  mass
percentage of iodine in the final terpolymer was kept constant, while the ratio
of  NVP to HEMA was varied.  These terpolymers also showed leaching of  NVP
oligomers, so they were also crosslinked. The combination of monomers shown
in Table 1 as T94_2, seemed interesting in terms of water content and
elasticity, so it was chosen to investigate this combination further.
The diffusion coefficient is used to estimate the time it takes for an implant of
that material, with given dimensions, to reach equilibrium swelling. For an
implant made out of T94_2 to swell to 1 cm lumbar disc height, the dry height
will  need  to  be 3 Q  =  1.26  times  smaller,  so  0.79  cm.  The  time  to  swell  to
equilibrium,  will  then  be  103  hours.  However,  an  implant  does  not  have  thin
sheet geometry, so diffusion from the edges is also present and will cause the
implant to reach equilibrium swelling quicker. In case of N94_2, the implant
height would need to be 0.78 cm and swelling to equilibrium would take (less
than) 62 hours.
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Regarding the mechanical characteristics, it should be noted that in situ, there
is a synergistic interaction between the nucleus pulposus and the annulus
fibrosus. This interaction is nearly impossible to replicate exactly in vitro.
Introducing an artificial annulus will only introduce more unknown variables,
hence it was chosen to perform the mechanical tests unconstrained. Since this
poses an unrealistic challenge to the material, the main objective of the fatigue
experiment was to see if the materials survive a million cycles, unconstrained.
One million cycles was chosen as a preliminary indication of fatigue resistance.
In a constrained situation, the materials are expected to perform even better.
Another feature to mimic a more realistic situation would be the introduction of
a resting period in the fatigue protocol to simulate sleep, in order to give the
materials a chance to recover. This would also lead to improved performance.
During unconfined compression the hydrogels display barrelling, which explains
the deviation from linearity at large strains in the static experiment. The
Young’s modulus of  a  nucleus prosthesis  needs to  be in  the range of  0.2 – 4
MPa in order to mimic the mechanical behaviour of the natural nucleus
pulposus [8, 39-41]. All materials are within this range. Périé et al. performed
confined compression tests on bovine nucleus pulposus and found the modulus
to be 0.31 MPa [42].
Obviously, the natural nucleus is less stiff and has a more fluid consistency than
our  materials  and also displays  a  high phase angle.  This  can be explained by
the high water content of the nucleus. It is desirable for nucleus replacement
materials to have a more solid consistency than the natural nucleus, so that
they do not flow through the defect in the annulus fibrosus, as the natural
nucleus does in case of HNP.
The natural disc creeps under loading, due to fluid flow [25].  During the day,
the discs are continuously loaded and this introduces a creep effect, resulting in
height loss. Overnight, the natural nuclei of the discs reswell and the disc
heights are restored. This explains why on average people are 2 cm taller in the
morning  than  in  the  afternoon  [43].  To  mimic  this  behaviour,  we  need  a
material that also recovers after loading.
5 Concluding remarks
The  new crosslinked  materials  N94_2  and  T94_2  were  compared  to  N94  and
H94.  Already,  the  materials  N94  and  H94  showed  to  be  good  candidates  for
nucleus replacement [15], concerning implantability, biocompatibility and
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radiopacity, but they were improved further by incorporating the crosslinker
AMA, without making concessions to these other properties. Introduction of this
crosslinker led to a significant reduction in the number of extractables,
improved elasticity and recovery after loading. Furthermore, the new materials
exhibit good fatigue behaviour. Both N94_2 and T94_2 are expected to be able
to cope with the strains occurring in the human intervertebral disc. They also
combine considerable water uptake with excellent radio-visibility.
The high water content and absence of metallic markers makes the hydrogels
easily detectable with MRI, whereas the covalently bound iodine renders them
intrinsically radiopaque.  While  the  spinal  column  is  a  very  bony  environment,
already 5-6 mass% of iodine is sufficient for visualizing the water-swollen
materials in between two vertebrae.
Our results reveal that it is possible to design radiopaque hydrogel biomaterials
that can replace the natural nucleus pulposus in terms of physical-mechanical
properties and biocompatibility. CT or MRI imaging techniques can be used to
evaluate the entire implant post-implantation. The next step in this research will
be to evaluate the tissue response and long term mechanical behaviour of the
prosthesis in vivo,  in  the  nucleus  cavity  of  an  appropriate  animal  model.  We
envisage that especially young patients, who suffer from HNP or early DDD, can
benefit from this strategy. This is a relatively small, but important subgroup of
back pain patients.
Acknowledgements
This research was funded by the Dutch Polymer Institute (DPI), project number
398, Intervertebral Disc Prosthesis. The authors would like to thank professor
Sjoerd Bulstra (Dept. of Orthopaedic Surgery, University Medical Center
Groningen, the Netherlands) and dr. André van Ooij (Dept. of Orthopaedic
Surgery, Academic Hospital Maastricht, the Netherlands) for constructive and
stimulating discussions.
References
1. Andersson  GB.  Epidemiological  features  of  chronic  low-back  pain.  Lancet  1999;
354: 581-585.
2. Koes BW, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain.
Bmj 2006; 332: 1430-1434.
Towards a Functional Radiopaque Hydrogel for Nucleus Pulposus Replacement | 87
3. Ihlebaek C, Eriksen HR. The "myths" of low back pain: status quo in norwegian
general practitioners and physiotherapists. Spine 2004; 29: 1818-1822.
4. Bao QB, Yuan HA. New technologies in spine: nucleus replacement. Spine 2002;
27: 1245-1247.
5. Guyer RD, Ohnmeiss DD. Intervertebral disc prostheses. Spine 2003; 28: S15-23.
6. Carl  A,  Ledet  E,  Yuan  H,  Sharan  A.  New  developments  in  nucleus  pulposus
replacement technology. Spine J 2004; 4: 325S-329S.
7. Di  Martino  A,  Vaccaro  AR,  Lee  JY,  Denaro  V,  Lim  MR.  Nucleus  pulposus
replacement: basic science and indications for clinical use. Spine 2005; 30: S16-
22.
8. Thomas  J,  Lowman  A,  Marcolongo  M.  Novel  associated  hydrogels  for  nucleus
pulposus replacement. J Biomed Mater Res 2003; 67A: 1329-1337.
9. Husson JL, Korge A, Polard JL, Nydegger T, Kneubuhler S, Mayer HM. A memory
coiling spiral as nucleus pulposus prosthesis: concept, specifications, bench
testing, and first clinical results. J Spinal Disord Tech 2003; 16: 405-411.
10. Ray CD. The PDN prosthetic disc-nucleus device. Eur Spine J 2002; 11 Suppl 2:
S137-142.
11. Bertagnoli R, Sabatino CT, Edwards JT, Gontarz GA, Prewett A, Parsons JR.
Mechanical testing of a novel hydrogel nucleus replacement implant. Spine J
2005; 5: 672-681.
12. Buttermann GR, Beaubien BP. Stiffness of prosthetic nucleus determines stiffness
of reconstructed lumbar calf disc. Spine J 2004; 4: 265-274.
13. Allen MJ, Schoonmaker JE, Bauer TW, Williams PF, Higham PA, Yuan HA.
Preclinical evaluation of a poly (vinyl alcohol) hydrogel implant as a replacement
for the nucleus pulposus. Spine 2004; 29: 515-523.
14. Boelen EJ,  van Hooy-Corstjens CS, Bulstra SK, van Ooij  A,  van Rhijn LW, Koole
LH. Intrinsically radiopaque hydrogels for nucleus pulposus replacement.
Biomaterials 2005; 26: 6674-6683.
15. Boelen EJH, van Hooy-Corstjens CSJ, Gijbels MJJ, Bulstra SK, van Ooij A, van
Rhijn LW, Koole LH. Preliminary evaluation of new intrinsically radiopaque
hydrogels for replacing the nucleus pulposus. Journal of Materials Chemistry
2006; 16: 824-828.
16. Joshi A, Fussell G, Thomas J, Hsuan A, Lowman A, Karduna A, Vresilovic E,
Marcolongo M. Functional compressive mechanics of a PVA/PVP nucleus pulposus
replacement. Biomaterials 2006; 27: 176-184.
17.  Benzina  A,  Kruft  MAB,  Bar  F,  van  der  Veen  FH,  Bastiaansen  CW,  Heijnen  V,
Reutelingsperger C, Koole LH. Studies on a new radiopaque polymeric
biomaterial. Biomaterials 1994; 15: 1122-1128.
18. Khare AR, Peppas NA. Swelling/deswelling of anionic copolymer gels. Biomaterials
1995; 16: 559-567.
19. Shin H, Temenoff JS, Mikos AG. In vitro cytotoxicity of unsaturated
oligo[poly(ethylene glycol) fumarate] macromers and their cross-linked hydrogels.
Biomacromolecules 2003; 4: 552-560.
88 | Chapter 4
20. Urban JP, McMullin JF. Swelling pressure of the lumbar intervertebral discs:
influence of age, spinal level, composition, and degeneration. Spine 1988; 13:
179-187.
21. White AA, Panjabi MM. Clinical biomechanics of the spine. Philadelphia:
Lippincott; 1978.
22. Crank J. The mathematics of diffusion. Oxford: Oxford University Press; 1990.
23.  Bajpai  AK,  Shrivastava  M.  Water  sorption  dynamics  of  a  binary  copolymeric
hydrogel of 2-hydroxyethyl methacrylate (HEMA). J Biomater Sci Polym Ed 2002;
13: 237-256.
24.  Knetsch  ML,  Aldenhoff  YB,  Hanssen  HH,  Koole  LH.  A  novel  synthetic  vascular
prosthesis: effect of plasma protein adsorption on blood - and cyto-compatibility.
Mat.-wiss. u. Werkstofftech. 2006; 37: In press.
25. Ghosh P. The biology of the intervertebral disc. vol. 2. CRC Press; 1988.
26. Maroudas A, Stockwell RA, Nachemson A, Urban J. Factors involved in the
nutrition of the human lumbar intervertebral disc: cellularity and diffusion of
glucose in vitro. J Anat 1975; 120: 113-130.
27. Eijkelkamp MF, van Donkelaar CC, Veldhuizen AG, van Horn JR, Huyghe JM,
Verkerke GJ. Requirements for an artificial intervertebral disc. Int J Artif Organs
2001; 24: 311-321.
28. Leahy JC, Hukins DW. Viscoelastic properties of the nucleus pulposus of the
intervertebral disk in compression. J Mater Sci Mater Med 2001; 12: 689-692.
29. Reid JE, Meakin JR, Robins SP, Skakle JM, Hukins DW. Sheep lumbar
intervertebral discs as models for human discs. Clin Biomech (Bristol, Avon) 2002;
17: 312-314.
30. Iatridis JC, Weidenbaum M, Setton LA, Mow VC. Is the nucleus pulposus a solid
or a fluid? Mechanical behaviors of the nucleus pulposus of the human
intervertebral disc. Spine 1996; 21: 1174-1184.
31. Iatridis JC, Setton LA, Weidenbaum M, Mow VC. The viscoelastic behavior of the
non-degenerate human lumbar nucleus pulposus in shear. J Biomech 1997; 30:
1005-1013.
32. Malak M, Hill DJT, Whittaker AK. Water sorption into poly[(2-hydroxyethyl
methacrylate)-co-(1-vinyl-2-pyrrolidone)]at 310 K. Polymer International 2003;
52: 1740-1748.
33. Atta AM, Arndt K-F. Swelling behavior of pH- and temperaturesensitive
copolymers containing 2-hydroxyethyl methacrylate and N-vinyl-2-pyrrolidone
crosslinked with new crosslinkers. Polymer International 2004; 53: 1870-1881.
34. Davis TP, Huglin MB. Studies on Copolymeric Hydrogels of N-Vinyl-2-Pyrrolidone
with 2-Hydroxyethyl Methacrylate. Macromolecules 1989; 22: 2824-2829.
35. Lai YC. Effect of Crosslinkers on Photocopolymerization of N-Vinylpyrrolidone and
Methacrylates to Give Hydrogels. Journal of Applied Polymer Science 1997; 66:
1475-1489.
Towards a Functional Radiopaque Hydrogel for Nucleus Pulposus Replacement | 89
36.  Beers  KL,  Boo  S,  Gaynor  SG,  Matyjaszewski  K.  Atom  transfer  radical
polymerization of 2-hydroxyethyl methacrylate. Macromolecules 1999; 32: 5772-
5776.
37. Diakoumakos CD, Raptis I, Tserepi A, Argitis P. Free-radical synthesis of narrow
polydispersed 2-hydroxyethyl methacrylate-based tetrapolymers for dilute
aqueous base developable negative photoresists. Polymer 2002; 43: 1103-1113.
38. Refojo MF. Hydrophobic Interaction in Poly(2-hydroxyethyl Methacrylate)
Homogeneous Hydrogel. Journal of Polymer Science; Part A-1 1967; 5: 3103-
3113.
39. Meakin JR. Replacing the nucleus pulposus of the intervertebral disk: prediction
of suitable properties of a replacement material using finite element analysis. J
Mater Sci Mater Med 2001; 12: 207-213.
40. Meakin JR, Reid JE, Hukins DW. Replacing the nucleus pulposus of the
intervertebral disc. Clin Biomech (Bristol, Avon) 2001; 16: 560-565.
41. Fagan MJ, Julian S, Siddall DJ, Mohsen AM. Patient-specific spine models. Part 1:
Finite element analysis of the lumbar intervertebral disc--a material sensitivity
study. Proc Inst Mech Eng [H] 2002; 216: 299-314.
42. Perie D, Korda D, Iatridis JC. Confined compression experiments on bovine
nucleus pulposus and annulus fibrosus: sensitivity of the experiment in the
determination of compressive modulus and hydraulic permeability. J Biomech
2005; 38: 2164-2171.
43. Roberts N, Hogg D, Whitehouse GH, Dangerfield P. Quantitative analysis of
diurnal variation in volume and water content of lumbar intervertebral discs. Clin
Anat 1998; 11: 1-8.
90 | Chapter 4
5
Evaluation of a Highly Radiopaque Iodine-
Containing Acrylic Bone Cement for Use in
Augmentation of Vertebral Compression
Fractures
Erik  J.H.  Boelen,  Gladius  Lewis,  Jie  Xu,  Tristan Slots,  Leo H.  Koole,  Catharina
S.J. van Hooy-Corstjens
Adapted from:
Journal of Biomedical Materials Research. Part A. Submitted
92 | Chapter 5
Abstract
Vertebroplasty and balloon kyphoplasty are widely used for the augmentation of
osteoporosis-induced vertebral compression fractures. Almost invariably, an
injectable poly(methyl methacrylate) (PMMA) bone cement that contains a large
amount of BaSO4 particles is used in these procedures. The deleterious effects
of this radiopacifier on various properties of PMMA cement have been detailed
in the literature. The objective of the present study was therefore to avoid such
high levels of inorganic contrast agent and thus to develop an all-polymeric
bone cement, for which radiopacity was provided by 60 wt.% of an iodine-
containing methacrylic copolymer, incorporated into the powder (IO cement),
ultimately  leading  to  6.6  wt.%  of  iodine  in  the  cement.  A  large  array  of
properties of this cement were determined, ranging from setting time and
injectability to fatigue life under fully-reversed tension-compression loading and
cytotoxicity,  and  a  comprehensive  comparison  with  a  cement  containing  30
wt.% BaSO4 in the powder component (BA cement) has been made (11 wt.%
of  Ba  in  the  cement).  Statistical  analyses  of  the  results  showed  that,  for  the
majority of the properties, the difference between the means for the two
cements was not significant. It is therefore suggested that the IO cement is a
suitable alternative to the BA cement for use in the aforementioned procedures.
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1 Introduction
Symptomatic compression fractures of vertebral bodies that occur secondary to
osteoporosis are a major public health issue. (For example, the annual direct
costs of these fractures are estimated to be ~$750 million and $440 million in
the US and in the European Union countries, respectively [1, 2]). Vertebroplasty
(VP) and balloon kyphoplasty (KP) are minimally-invasive surgical procedures
that are rapidly becoming popular modalities for the stand-alone augmentation
of these fractures, especially those that have proved to be refractory to
conservative methods and/or medical therapy [3, 4]. (An estimated 38,000 VPs
and 16,000 KPs were performed in the US in 2002 [5]). Each of these
procedures involves the percutaneous delivery of a bolus of an injectable bone
cement into the fractured vertebral body, carried out under very careful
fluoroscopic image guidance [6]. Because of its long history of successful use in
cemented total joint replacements (CTJRs), poly (methyl methacrylate) (PMMA)
bone cements are used in most VPs and KPs. Whereas contemporary acrylic
bone  cements  for  CTJR  contain  10-15  wt.%  of  radiopacifier  in  the  powder
phase, cements for VP and KP require a higher radiopacifier content for
improved visualization under X-ray fluoroscopy. This is achieved by using either
a commercially-available brand that is formulated specifically for such use (for
example, KyphX®HV-RTM, which contains 30 wt.% BaSO4, and Osteopal® V,
which contains 33 wt.% ZrO2 particles) or one that is traditionally used in CTJRs
(for example, Surgical Simplex®P, which contains 10 wt.% BaSO4 particles) but
with extra amounts (typically, 6-10 g) of BaSO4 or ZrO2 particles and/or 1-2 g of
tantalum or tungsten powder hand mixed, by the surgeon/nurse, into the
cement powder just prior to injection [6-10].
Concerns have been raised about this practice. In the case of BaSO4 particles, it
has been shown that (i) increased concentration leads to decreases in a
number of quasi-static mechanical properties of a cement that are relevant to
its use in VP and KP, such as fracture toughness and flexural strength [11, 12],
as well as in fatigue life [13]; and (ii) they tend to form clumps in the powder
which, in turn, act as fatigue crack initiation sites [14]. Furthermore, in
skeletally mature sheep, foreign-body giant cells were observed, at 90 days,
around BaSO4 particles in the case when a PMMA cement containing 30 wt.%
BaSO4 was used whereas few such particles were observed, after the same
period, when a cement containing 10 wt.% BaSO4 was used [15]. ZrO2 particles
are very hard and not compatible with the polymer matrix [16]. Both BaSO4 and
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ZrO2 particles have been shown to enhance macrophage-osteoclast
differentiation, which may contribute to bone resorption, which is particularly
undesirable in osteoporotic persons [17]. The influence of W or Ta powders on
the cement properties is unknown [18].
To  avoid  using  high  levels  of  inorganic  contrast  agents,  we  developed  an  all-
polymeric radiopaque bone cement. Radiopacity was introduced by
incorporating an iodine-containing methacrylic copolymer into the cement
powder. This copolymer was prepared as a 1/1 w/w copolymerization of methyl
methacrylate (MMA) with a methacrylic monomer containing covalently bound
iodine (2-[4’-iodobenzoyl]-oxo-ethyl methacrylate, 4IEMA) [19]. There are a
number of articles in the literature about iodine-containing acrylic bone
cements, with the iodine present in either the liquid monomer [20, 21] or, as in
our approach, in the powder [19, 22-24]. However, all of these cements were
developed for use in CTJRs, implying that the radiopacity will be too low for VP
and KP. In our previous studies, it was shown that a bone cement with low
amounts of an iodine-containing methacrylic copolymer (3.5 wt.% iodine)
present in the powder component of the cement, displayed good fatigue
performance and excellent biocompatibility [19, 23, 24]. Building on these
results, we have prepared an acrylic bone cement for which the content of
iodine-containing copolymer (I-copolymer) has been increased to an iodine
content of 10.6 wt.% of the powder. Thus, this new cement (herein called the
IO cement) is intrinsically radiopaque at a level that is deemed acceptable for
VP and KP.
The present work is a comprehensive comparison of the IO cement and a 30
wt.% BaSO4-containing PMMA bone cement (BA cement) on the basis of a wide
collection of in vitro physical, handling, thermal, mechanical, and cytotoxic
characteristics. Even though these properties include a sizeable proportion of
those  that  have  been  suggested  as  being  important  for  an  injectable  bone
cement to be used in VP and KP [6, 11], the comparison between BA and IO
cements is limited by two facts. First, there are no standards for characterizing
injectable bone cements for use in VP and KP. Second, there are only a very
few acrylic bone cement brands that are formulated specifically for use in VP
and KP and, for these cements, there are no data for the large majority of the
properties determined in the present work. The present study should therefore
be regarded as a contribution to the development of (i) a new generation of
injectable acrylic bone cements for use in VP and KP, and (ii) standards for
characterizing these cements.
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2 Materials and Methods
2.1 Materials
To  make  a  fair  comparison  between  the  BA  and  IO  cement,  all  components,
except the radiopacifier, should be the same. Therefore, all experiments were
performed with own-made cement, based on own-made PMMA microspheres.
These microspheres were prepared via a suspension polymerization technique,
using benzoyl peroxide (BPO), as the initiator. Some of the initiator remained in
these microspheres after completion of the reaction, with the residual BPO
content being determined, by titration, to be 2.27 wt.%. The I-copolymer
(copolymer  of  MMA  and  4IEMA  (mass  ratio  1/1)),  which  was  used  as  the
radiopacifier for the IO cement, was also prepared via a suspension
polymerization reaction. The resulting microspheres had a residual BPO content
of 1.11 wt.%. The compositions of both cements are given in Table I. For VP
and KP, liquid monomer-to-powder ratio’s (LPR) between 0.22 and 1.43 mL g-1
have been described in literature [7-10]. In the present study, we used a LPR
of 0.65 mL g-1.
Table 1: Compositionsa of the cements
Powder (g) Liquid monomer (g)
Cement
PMMA BaSO4
I-
copolymer
BPO MMA DMPT HQ
BA
cement
27.36 12.0 0.0 0.64 23.4 0.6 20b
IO
cement
15.64 0.0 23.73 0.63 23.4 0.6 20b
aPMMA: poly (methyl methacrylate); MMA: methyl methacrylate; I-copolymer:
copolymer of MMA and 2-[4’-iodobenzoyl]-oxo-ethyl methacrylate (1/1 w/w);
BPO: benzoyl peroxide; DMPT: N,N-dimethyl-p-toluidine; HQ: hydroquinone.
bIn ppm.
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2.2 Characterization of powders
The particle size distributions of both the PMMA spheres and I-copolymer
spheres were determined by measuring the diameters of 500 microspheres
using light microscopy. The morphologies of the cement powders were obtained
using a scanning electron microscope (XL30; Philips, Eindhoven, The
Netherlands) operating at an accelerating voltage of 15 kV.
2.3 Preparation and morphology of as-cured cements
For the determination of cement properties, the powder and the liquid
monomer were mixed using an open-bowl technique (hand mixing), under
ambient laboratory conditions (temperature and relative humidity of 20 ± 1 ºC
and 55 ± 2 %, respectively),  as  is  commonly  done in  VP and KP [7-10].  The
morphologies of the as-cured cements were obtained using machined disc
specimens  (diameter  and  height  of  10  mm  and  1  mm,  respectively)  and  a
scanning electron microscope (XL30; Philips Eindhoven, The Netherlands)
operating at an accelerating voltage of 10 kV in the backscatter mode.
2.4 Evaluation of radiopacity
A cured cement disc (diameter and thickness of 12 mm and 3 mm, respectively)
was  irradiated  with  X-rays  (Philips  BV  Pulsera;  46  kV,  1.04  mAs,  autofocus),
much as is done in clinical practice. Following a method that has been described
in the literature [25], a commercially-available image editing software
(Adobe®Photoshop®;  Adobe,  Inc.,  San  Jose,  CA)  was  used  to  measure  the
brightness of the disc in the resulting image, averaged over an area of 5 pixels
× 5 pixels. The radiopacity of the cement was then determined as the ratio of
its  darkness  (=  100  –  brightness)  to  that  of  aluminum  (thickness  3  mm),
measured using the same procedure. Also the radiopacity of a 10 wt.% BaSO4
cement for CTJR was determined for comparison. Measurements were made in
six-fold.
2.5 Injectability tests
These were carried out using a method proposed by other authors [26, 27]. 1
min after mixing the cement, the dough was charged into a 20-mL disposable
syringe that was attached to a bone biopsy needle (diameter and length of 1.6
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mm and 150 mm, respectively). Through a universal materials testing machine,
a  1-kg  compressive  load  was  applied  to  the  top  of  the  syringe’s  plunger.
Injectability  was  defined  as  the  mass  of  cement  dough  extruded  through  the
needle into a poly (tetrafluoroethylene) beaker, over a period of 1 min, as a
proportion of the mass of cement charged into the syringe.  Six measurements
were made for each cement.
2.6 Residual monomer content
The residual monomer content (RMC) of the fully cured cements was
determined using proton nuclear magnetic resonance (1H-NMR) spectroscopy
(Varian Mercury 400; Varian Corp., Palo Alto, CA, USA), operating at 400 MHz,
with tetramethylsilane as the internal standard. Approximately 50 mg of the
cured cement was accurately weighed at different time points, t, after curing (t
=  1  day,  1  week,  1  year)  and  dissolved  in  2.5  mL  deuterated  acetone.  A
solution of 1 mg mL-1 MMA in deuterated acetone was also prepared. For each
combination of cement and t, 400 ?L of the cement solution, together with 0,
100, 200 or 300 ?L of the MMA solution was transferred to an NMR-tube and
completed to 700 ?L using pure deuterated acetone. The NMR spectrum of the
mixture was then recorded. The vinyl proton signals in the spectrum (singlets at
5.6 and 6.0 ppm) (Figure 1A) were integrated and set to 100 arbitrary units for
the cement solution.  This integral, together with those when the mixture
contained cement solution and known added amounts of MMA (100, 200, 300
?g), were plotted and the best-fit trend line was obtained (Figure 1B). The
intersection of this trendline with the x-axis represents the amount of MMA
present in the cement solution. With this value, the percentage of residual
monomer in the dissolved cement was calculated.
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Figure 1: (A) Expanded view (? = 5.5-6.1 ppm) of a typical 400 MHz 1H-NMR
spectrum of  acrylic  bone cement,  showing the vinyl  proton signals  of  residual
MMA and (B) typical trendline-curve for the determination of the residual
monomer content, using 1H-NMR.
2.7 PBS uptake
The gain in the mass of a circular cross-sectioned cement disc specimen
(diameter and length of 2.80 and 8.00 mm, respectively), which was immersed
in  40  mL  of  phosphate  buffered  saline  (PBS),  pH  7.4,  at  37  ±  0.5  ºC,  was
monitored continuously until there was no significant increase; that is, process
equilibrium was reached.
The early stages of the uptake (Mt/M? < 0.6), are describable by a reduced
form  of  an  applicable  solution  to  Fick’s  Second  Law  of  Diffusion  (Stefan’s
approximation), which is [28]:
50
24
.
t
l
Dt
M
M
÷
ø
ö
ç
è
æ=
¥ p
, (1)
where Mt and M????are the mass gains of the specimen after time, t, in the PBS
solution, and at the equilibrium stage, respectively. Thus, D (the diffusion
coefficient) was computed from the slope of the linear plot of Mt/M? versus ?t.
For each cement, three specimens were tested.
2.8 Handling properties
The setting time (tset) and the maximum exotherm temperature (Tmax) were
determined, in ambient laboratory air (20 ± 1 ºC). The liquid monomer and
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powder  were  hand  mixed  with  a  spatula,  25  g  of  the  cement  mixture  was
insulated  in  aluminium foil,  and  a  thermometer  was  inserted  in  the  middle  of
the dough. The temperature was recorded every 10 s until polymerization was
complete.  For each cement, the test was run in duplicate.
2.9 Bulk quasi-static mechanical properties
The compressive yield strength (YS) and compressive modulus (E) were
determined using machined solid cylindrical test specimens (diameter and
height of both 6 mm) and a servohydraulically-actuated universal materials
testing machine (MTS 810 Elastomer Test System; MTS, Eden Prairie, MN, USA)
operated at a true strain rate of 3 × 10-3 s-1.  YS is defined as the stress at the
point of permanent yield, zero slope, on the stress-strain curve. Before testing,
the samples were incubated in water at 37 ºC till equilibrium was reached. For
each cement, six specimens were tested.
The plane-strain fracture toughness (KIC) of each cement was determined using
ASTM D 5045 compact tension fracture toughness (KIC) specimens [29] having
width, thickness, and initial crack length of 37.17, 14.87, and 14.87 mm,
respectively. The moulded specimens were cured for 2 h, after which they were
removed from the mould, lightly sanded, and then conditioned in PBS, at 37 ºC,
for  28  d.  The  KIC tests were carried out, in ambient laboratory air, using a
servohydraulically-actuated universal materials testing machine (Bionix 810;
MTS, Eden Prairie, MN, USA), under displacement control, with a cross-head
speed of 10 mm min-1. All other test procedures and data analysis methods
followed were as given in ASTM D 5045. For each cement, six specimens were
tested.
2.10 Quasi-static nanoindentation properties
Moulded specimens (45 mm × 12 mm × 5 mm bars) were stored in PBS, at 37
ºC until they reached equilibrium mass (this took 23 ± 1 d), before the tests
were performed using a commercially-available nanoindentation instrument
(TriboIndenter®; Hysitron, Inc., Minneapolis, MN, USA).
The indenter was driven into the surface of the specimen at a constant loading
rate of 30 ?N s-1 until  a peak load of 260 ?N was reached. The values of the
hardness, HN,  and  elastic  modulus,  EN, were calculated using the Modified
Slopes Method, MSM [30]. Further details about (i) specimen preparation, the
performance of the test, data acquisition, and the treatment of the data using
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MSM to obtain HN and EN for acrylic bone cement specimens; (ii) the reason for
using MSM, rather than the well known Oliver-Pharr method; and (iii) validation
of the test have all been given previously [31]. Three specimens per cement
were tested.
2.11 Fatigue performance
The test specimen configuration and size, specimen preparation, specimen
examination and, hence, selection for testing, specimen conditioning, and test
procedures were all as detailed in ASTMF 2118-03 [32]. Stress levels (S) of ±
10 MPa, ± 15 MPa, and ± 20 MPa were used. The rejection rates (number of
specimens discarded after inspection, as detailed in the standard, as a
proportion of the total number of specimens moulded) were 40% and 45% for
BA cement and IO cement specimens, respectively, values that are within the
range reported in the literature [33]. For each combination of cement and S of
± 20 MPa or  ± 15 MPa,  12 specimens selected at  random from the accepted
specimens were tested, consistent with the recommendation of Lewis and
Sadhasivini [34]. (For S of ± 10 MPa, 8 specimens were used for each cement
because of time constraints — some specimens experienced “run-out”; that is,
no fatigue failure after 1.5 million stress cycles).
The  cycles  to  fracture,  Nf, results were used in the estimation of the fatigue
limit of the cement through the use of the Olgive equation [35]:
S = A + (B-A)/(1+(ln Nf/C)D), (2)
where A, B, C, and D are material constants.
(In  this  case,  the  parameter  of  interest  was  A,  which  was  taken  to  be  the
“fatigue limit” of the cement). A commercially-available software (Matlab®
Version 7.0, The MathWorks, Natick, MA, USA) was used in the curve-fitting
exercise.
For each cement, the morphology of the fracture surfaces of the fatigue
specimens,  at  S  =  ±  15  MPa,  was  obtained  using  a  scanning  electron
microscope (Model XL30; Philips, Eindhoven, the Netherlands), operating at an
accelerating voltage of 15 kV. (This value of S was chosen because, of the
three values of S used, it is the lowest value for which all the specimens in both
sets fractured).
Evaluation of a Highly Radiopaque Iodine-Containing Acrylic Bone Cement for Vertebroplasty | 101
2.12 Dynamic nanomechanical properties
Moulded specimens (45 mm × 12 mm × 5 mm bars) were stored in PBS, at 37
ºC  until  they  reached  equilibrium mass  (this  took  23  ±  1  d)  before  the  tests
were performed using a commercially-available nanoindentation instrument
(TriboIndenter®).
The indenter was driven, under computer control, toward the surface of the
specimen, at a constant rate of 10 nm s-1, until it contacted the surface. Upon
contact, a small, constant oscillatory load of 15 ?N, at a selected value of ? (1-
200 Hz, in steps of ~7 Hz), superimposed on a quasi-static load of 200 ?N, was
applied to the surface. The values of the storage modulus (E’) and loss modulus
(E”), at a given value of ? were determined assuming that the head assembly
of the instrument may be modelled as a simple damped harmonic oscillator
[36]. Further details of (i) specimen preparation, performance of the test, data
acquisition, and the treatment of the data using the aforementioned model to
obtain E’ ?and E” for acrylic bone cement specimens; (ii) validation of the test;
and (iii) the limitations of the experimental method used have all been given
previously [37]. Three specimens per cement were tested.
2.13 Cytotoxicity tests
Small fragments (total mass of approx. 0.25 g) of the cured cements, exposed
to ambient laboratory air for 2 months were sterilized using ultra-violet light
and  then  put  in  approx.  2.5  mL  (final  concentration  0.1  g  mL-1) cell culture
medium (Minimum essential medium with Earle’s salts, Glutamax-I, and 25 mM
HEPES  and  supplemented  with  10wt.%  fetal  bovine  serum  and
antibiotic/antimycotic solution (1×)) at 37 ºC. The medium was removed after 2
d, stored at 4 ºC, and fresh medium was added. This was repeated twice. The
collected media were put on osteoblast cells (SAOS-2). After 3 d, a methyl
thiazol  tetrazolium (MTT) assay [38]  was conducted and the cell  survival  was
calculated by measuring the optical absorbance at 550 nm. The cell survival in
pure culture medium was set to 100%. All tests were run in triplicate.
2.14 Statistical analysis
The results for the cement properties were statistically analyzed using ANOVA,
with the Bonferroni correction, and the 95% confidence limits for the
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differences between population means (SAS® Version 8.02; SAS Institute Inc.,
Cary, NC, USA).
3 Results
3.1 Powder characteristics and morphology of as-
cured cements
The number average particle diameter of the PMMA and I-copolymer spheres
was found to be 15.4 ± 13.2 ?m and 14.9 ± 12.9 ?m respectively, whereas the
weight average particle diameter was 86.6 ± 72.5 ?m and 89.9 ± 76.2 ?m
respectively. The size distribution diagrams can be seen in Figure 2. Clearly,
there is no significant difference between the sizes of the PMMA and I-
copolymer spheres. So, the main difference between the cement powders is the
presence of BaSO4 particles in the BA cement powder, which can clearly be
seen in the SEM images (Figure 3).
Figure 2: Size distribution diagrams of PMMA and I-copolymer microspheres;
(A) number-weighted distribution diagram and (B) mass-weighted distribution
diagram.
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Figure 3: Scanning electron micrographs of the powder of (A) BA cement and
(B)  IO cement.  Mark that,  in  the BA cement,  the BaSO4 particles are seen as
white clusters. (Scale bar is 100 µm).
The radiopacifier in the BA powder is seen as discrete white clusters (Figure
3A), while it is indistinguishable as such from the IO powder (Figure 3B), which
is  to  be  expected  because  the  radiopacity  is  incorporated  in  60%  of  the
spheres. The different radiopacifiers in the two cements are more clearly seen
in the backscatter images of the as-cured cements (Figure 4). In the BA cement
(Figure 4A), BaSO4 particles and lumps (white) are clearly visible between the
black PMMA microspheres. In the IO cement (Figure 4B), there are light
spheres (I-copolymer) and dark spheres (PMMA microspheres). Also, the
surrounding matrix in the IO cement is somewhat lighter, due to the presence
of the I-copolymer in the matrix, as a result of the partial dissolution of the I-
copolymer in the matrix during mixing of the liquid monomer and the powder.
The penetration of the MMA into the I-copolymer spheres during the mixing is
apparent from the darkened corona of the light spheres.
Figure 4: Backscatter scanning electron micrographs of the as-cured cements,
clearly showing the difference in radiopacifier between (A) BA cement and (B)
IO cement. (Scale bar is 200 µm).
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3.2 Physical, handling, polymerization, and bulk
mechanical properties
The values of all these properties for the BA and IO cements are presented in
Table II.
The radiopacity of both cements exceeds that of aluminium of the same
thickness  (108.2%  for  IO  cement  and  132.9%  for  BA  cement)  and  it  is  also
considerably higher than that of acrylic bone cement used in CTJRs, which was
found to be average 66%. The difference between the cements was found to
be significant (Figure 5 and Table III).
When mixing the cements, a clear difference in rheology was observed between
them, with IO cement flowing more easily than BA cement during the very early
stage of the test. This difference is not reflected in the injectability results,
which show no significant difference between the cements (Table III).
Figure 5: Radiograph of 3 mm thick discs of the cements and of an aluminium
step wedge (1 to 5 mm thick, 1 mm steps).
For both cements, as expected, the RMC decreases markedly with increase in
time after curing, and, after 1 y, the RMCs of the two cements are essentially
the same (< 1%, Table II).
The fact that there is no significant difference in the diffusion coefficients for
the uptake of PBS by the two cements points to the possibility that the uptake
mechanism – infiltration of the fluid into the micro-voids or molecular
interaction  of  available  hydrogen  bonds  at  the  hydrophilic  sites  [39]  –  is  the
same for both cements.
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The IO cement polymerizes significantly faster but with a significantly lower
maximum exotherm temperature than the BA cement (Table III). Although the
residual BPO content in the I-copolymer microspheres was adjusted to ensure
that the total amount of BPO in the powder phase was equal in both cements,
the availability of BPO is different. Since IO cement contains more microspheres
(100% microspheres in the powder of the IO cement versus 70% microspheres
in the powder of the BA cement), the surface area for MMA to diffuse into the
spheres is larger. This explains the faster polymerization of IO cement. (Note
that, in both cements, all the BPO is present in the form of residual BPO in the
microspheres and no free BPO is added). During VP or KP, the injectable bone
cement bolus is introduced percutaneously into the body of the fractured
vertebra, so a lower Tmax is desirable to avoid excessive thermal necrosis [40].
Mechanically, there is no significant difference in either the YS or the KIC values
for the two cements. Furthermore, for both HN and  EN, the difference in the
means for the two cements is not significant (Table III).
The fatigue limits were estimated to be 10.4 MPa (95% confidence limits: 8.3-
12.5 MPa) for IO cement and 10.0 MPa (95% confidence limits of 8.1-11.8
MPa) for BA cement (Figure 6).
However, there are two features of the fatigue limit estimation results that need
comment.  First,  the  computed  curve  does  not  approach  a  lower  asymptotic
stress  value,  which  should  be  the  fatigue  limit.  Second,  some  specimens
suffered fatigue at ± 10 MPa. In other words, the estimation of the fatigue limit
using the Olgive equation is problematic for these cements, a situation that may
be a consequence of the extensive overlap of the Nf results  obtained at  ± 20
MPa  and  ±  15  MPa.  In  light  of  these  points,  it  may  be  prudent  to  adopt  the
lower  95%  confidence  level  estimates  as  the  fatigue  limits.  Also,  there  is  a
marked difference in the morphologies of the fracture surfaces of the BA and IO
cements (Figure 7), with the BA cement fracture surface comprising some
sectioned PMMA microspheres and pores that were most likely the sites of crack
initiation, and the IO cement fracture surface being characterized by smooth,
almost glass-like, stacked plateaux. More important than the relative values of
the estimated fatigue limits of the two cements is the fact that both estimates
are within the range that the present authors computed for KyphX®HVR
cement, which is a high-radiopacity PMMA cement that is currently used in VP
and KP. (This estimate, 9.3 MPa, with 95% confidence intervals of 7.0 and 11.5
MPa, was obtained from the fit of  the tension-compression fatigue life results
given by Kurtz et al. [13] to Equation (2)).
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Figure 6: The fatigue life (Nf) results and fits to the Olgive equation with the
associated 95% confidence intervals for (A) BA cement and (B) IO cement.
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Figure 7: The morphologies of the fracture surfaces of representative fatigue
specimens of (A) BA cement and (B) IO cement. (Scale bar is 100 µm).
The results of the dynamic nanoindentation tests (Figure 8) showed that the
difference in the viscoelastic behaviour of the cements was not significant. For
example, (i) the E’? values range from 3.85 ± 0.74 GPa at 1 Hz to 5.52 ± 1.00
GPa at 200 Hz for the BA cement and from 3.74 ± 0.43 GPa at 1 Hz to 5.28 ±
0.50 GPa at 200 Hz for the IO cement; and (ii) the minimum value of E” (~0)
occurs at an applied frequency of ~83 Hz and ~77 Hz for BA and IO cements,
respectively.
3.3 Cytotoxicity performance
In the cytotoxicity test, the first extract of both cements appeared to be toxic to
the osteoblast cells, since cell survival was low (<1%) (Table II). The second
extract of the IO cement was found to be considerably less toxic than that of
the BA cement. Apparently less toxic substances dissolve from the IO cement.
This difference could not be seen anymore in the third extract.
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Figure 8: Typical results of the variation of the storage modulus and the loss
modulus with frequency of the applied load, obtained in the dynamic
nanoindentation tests for (A) BA cement and (B) IO cement.
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Table 2: Summary of the values of the properties of the cements.
Property BA cement IO cement
Radiopacity (% of aluminum) 132.9 ± 3.6 108.2 ± 8.3
Injectability (%) 88.3 ± 2.2 85.8 ± 3.1
Residual monomer content (1 day;
1 week; 1 year) (%)
5.3; 2.4; 0.2 8.4; 2.9; 0.9
Diffusion coefficient, D × 1012 (m2
s-1)
4.26 ± 0.75 3.66 ± 0.59
Setting time, tset (min) 18.5 ± 0 12.5 ± 0
Maximum exotherm temperature,
Tmax (oC)
101± 0.7 94 ± 0.7
Compressive yield strength, YS
(MPa)
60.5 ± 3.9 57.6 ± 5.9
Compressive modulus, E (MPa) 1610 ± 130 1736 ± 40
Fracture toughness, KIC (MPaÖm) 1.61±0.05 1.58 ± 0.07
Fatigue limit (MPa) 10.0 10.4
Hardness, HN (MPa) 204 ±11 210 ± 16
Elastic modulus, EN (GPa) 3.67 ± 0.26 3.73 ± 0.24
Cytotoxicity (% cell survival of 1st,
2nd, and 3rd extract)
0.3 ± 0.1; 20.8 ±
4.3; 72.1 ± 8.5
0.6 ± 0.1; 58.9
± 9.1; 70.6 +
8.1
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Table 3: Results of the ANOVA, with Bonferroni post hoc, on results of IO
cement versus those of BA cement.
Property
Difference
between
means
Simultaneous
95% confidence
limits
Outcomea
Radiopacity (%
of Al)
-24.70 -32.93; -16.47 S
Injectability
(%)
-2.50 -5.96; 0.96 NS
D  ×  1012 (m2
s-1)
-0.60 -2.13; 0.93 NS
tset (min) -6.00 -6.00; -6.00 S
Tmax (oC) -7.00 -10.01; -3.99 S
YS (MPa) -2.90 -24.42; 18.62 NS
E (MPa) 126.00 2.28; 249.72 S
KIC (MPaÖm) -0.03 -0.11; 0.05 NS
HN (MPa) 6.00 -25.12; 37.12 NS
EN (GPa) 0.06 -0.51; 0.63 NS
Cytotoxicity 1st
extract
0.30 0.21; 0.39 S
Cytotoxicity 2nd
extract
38.10 31.41; 44.79 S
Cytotoxicity 3rd
extract
-1.50 -9.30; 6.30 NS
aS: difference between means is significant; NS: difference between means is
not significant
4 Discussion
There is a growing literature on the characterization of highly-radiopaque acrylic
bone cements that are used or are proposed for use in VP and KP [13, 26, 41-
50]. However, (i) in each of these studies, the cement used contained an
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inorganic material as the radiopacifier; (ii) in some studies, only a few
properties were determined [41-47, 49, 50]; (iii) in vitro and in vivo
biocompatibility of the cements was determined in only two studies [47, 48];
(iv)  the uptake of  a  physiological  salt  solution (0.9% NaCl,  at  37 ºC)  was the
subject of one study [47]; and (v) residual monomer content was determined in
only one study [26]. In contrast, in the present study, (i) for one of the
cements, we utilized an innovative approach to produce high radiopacity
without using any inorganic materials; and (ii) all the aforementioned properties
(except the in-vivo biocompatibility), together with an array of other relevant
ones, were determined. Thus, the present study is the most comprehensive to
date.
There are no standards for the determination of any properties (and, hence,
there are no property limits) of highly-radiopaque acrylic bone cements for use
in VP and KP. However, the present injectablity, RMC, tset, Tmax, and YS results
are within the ranges reported for other high-radiopacity acrylic cements that
are being used in VP and KP [13, 41, 42, 50] or have been suggested as having
the potential for such use [26, 48].
In the present study, the fatigue performance under fully-reversed tension-
compression loading was determined. This, arguably, represents the most
aggressive  type  of  alternating  loading.  Soltesz  et  al.  [51]  found  that,  for  two
acrylic bone cements that are widely used in CTJRs, fatigue strength at 107
cycles (which may be taken as the fatigue limit), under fully-reversed tension-
compression load is only 8-18% and 15-34% that under cyclic 4-point bend and
cyclic tension-tension, respectively. Thus, the fatigue limits estimated for BA
and IO cements may be regarded as being conservative. Intradiscal pressure
measurements at the L4-L5 level, made with a telemetric system, suggest that
the compressive stresses on lumbar vertebrae during normal activities of daily
living  range  from  0.1  MPa  to  2.3  MPa  [52].  Thus,  given  the  fatigue  limits
estimated for BA and IO cements (~8-12 MPa), it is unlikely that a fractured
vertebral body augmented using VP or KP and either of these cements will
suffer fatigue failure.
Clinically, the final curing of the bolus occurs at a temperature closer to 37 ºC
than to the operating room temperature (typically, 21 ºC).  It is known that tset
and Tmax of an acrylic bone cement decreases and increases, respectively, with
increase in measurement temperature [11]. Another point of consideration is
that Tmax is largely influenced by the amount of cement used, due to an auto-
acceleration effect of the polymerization reaction. These factors make it very
difficult  to  relate  the  observed  values  to  actual  setting  times  and  maximum
exotherm temperatures that will be obtained in the clinical setting.  (No
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comments can be made regarding the acceptability of these “clinically-relevant”
values because there are no stated limits for tset and  Tmax for  acrylic  bone
cements for VP and KP).
In VP and KP, the injected cement bolus is required to mechanically interlock
with the bone. Thus, strictly speaking, in the determination of the in vitro
mechanical properties of the cement, a technique that characterizes the
outermost layers of a cement specimen should be used; that is, the technique
should allow determination of property measures at the microstructural scale at
or near the surface. It was for this reason that the nanoindentation technique
was used in the present study to obtain both quasi-static and dynamic
mechanical properties. (The displacement noise floor or displacement
sensitivity, of a nanoindentation instrument is, typically, between 0.1 and 0.3
nm). Only few reports are available on HN and EN of acrylic bone cements and
these are for the low-radiopacity brands [31, 37]. There are a number of
literature studies on E’ ?and ??E” of low-radiopacity acrylic bone cements, as a
function of  test  temperature,  at  a  fixed value of  ? (in  most  cases,  1  Hz)  [20,
53, 54], but very few on E’ ?and E” as a function of ?, at a fixed temperature
[37, 55], with nanoindentation used in only one case [37].
It has been shown that an iodine-containing acrylic bone cement that differs
from  the  one  used  in  the  present  study  only  in  the  amount  of  the  iodine-
containing copolymer incorporated into the powder (20 wt.% versus 60 wt.% in
the present study) is biocompatible [24]. This finding, coupled with the results
of  the  present  MTT  assays,  leads  us  to  believe  that  IO  cement  is  also
biocompatible.
IO cement is in the development phase and, so, there is scope for modifying its
properties through, for example, optimizing its composition and the LPR used;
for example, (i) increasing the BPO content will lead to a decrease in tset but
Tmax may increase [11]; and (ii) decreasing the LPR may lead to decreases in
both tset and Tmax [11]. (Clinicians will find information regarding the influence
of  LPR on tset and Tmax particularly  helpful).  It  must  also be remembered that
the iodine content of the I-copolymer and the amount of I-copolymer in the IO
cement (which determine the cement’s radiopacity) were selected on an
empirical basis (for both cements the fraction of radiopacifier in the powder
component has been increased by a factor 3 compared to cements for CTJRs),
with  the  expectation  that  the  cement’s  radiopacity  will  be  about  the  same  as
that for the BA cement. In other words, the radiopacity of the IO cement can
easily be increased by increasing the iodine content from its current level of
10.6  wt.%.  (Of  course,  the  extent  to  which  this  increase  will  affect  other
properties of the curing and cured cement will need to be investigated).
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Further characterization of both BA and IO cements should include obtaining (i)
the fatigue limit of the cements, under tension-compression loading using a
more direct and time-saving method, such as thermography [56]; (ii) cement
injection data, such as syringe pressure-versus-injection time (T) and injected
cement volume-versus-T profiles; (iii) cement resorption and osteoconductivity
patterns; and (iv) the compressive fatigue lives of osteoporotic cadaveric
vertebral bodies, augmented using the cement, while immersed in an
appropriate biosimulating solution, at 37 ºC. Clearly, all the aforementioned
properties and those determined in the present study are important in
characterizing the cements. However, it is stressed that the ultimate
comparison of the cements can only be obtained from well-designed,
randomized, controlled clinical trials of VP and KP in which the subjects in the
study  groups  are  matched  (for  age,  sex,  weight,  and  numbers)  and  all  the
variables, notably, level(s) augmented, number of levels augmented, surgical
technique (unipedicular versus bipedicular approach), and volume of cement
injected, are the same for the study groups except for the cement used.
5 Conclusions
A large collection of properties were determined for two highly-radiopaque
acrylic bone cements that have the same composition but differ only in the
radiopacifier used; 30 wt.% BaSO4 particles   (BA  cement)  or  60  wt.%  of  an
iodine-containing copolymer incorporated in the powder (IO cement). For a
majority of these properties, the difference in the means was not significant.
Given the concerns that have been raised about BaSO4 particles in acrylic bone
cement, the present results suggest that IO cement is a viable alternative to
high BaSO4-containing cement in procedures for augmenting osteoporosis-
induced vertebral compression fractures, such as vertebroplasty and balloon
kyphoplasty.
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Two discoveries that more or less revolutionized the world of medicine were:
1)  The  discovery  of  X-rays  by  Wilhelm  Röntgen  in  1895,  which  enabled
surgeons to look into a human body without cutting it open. With the rise of the
computer it became even possible to make 3D reconstructions using X-rays: a
technique called computed tomography.
2)  Since Harold  Ridley in  1949 recognized that  pilots  in  the airforce,  who had
suffered penetrating injuries to the eye from the plastic windshields of the
aircraft, showed no adverse reactions to the material in the eye after the initial
trauma had quieted, polymers were introduced into medicine [1]. Because of
the  versatility  of  polymers,  they  have  found  widespread  use  in  all  kinds  of
medical applications.
Unfortunately it is difficult to combine these discoveries, since polymers consist
primarily  of  the  lower  elements  C,  H,  O  and  N,  which  makes  it  impossible  to
visualize them, using X-rays, inside the human body. To date, this is overcome
by the addition of metal markers or inorganic contrast agents to the polymeric
biomaterial. These additions however, solely for the purpose of radiopacity, can
have a negative effect on implant behaviour. Therefore we believe it is better to
provide polymers with intrinsic radiopacity. This is achieved by covalently
binding one (or more) iodine atom(s) to a polymer building block.
In this thesis the focus was on intrinsically radiopaque polymeric biomaterials
for spinal surgery, more specifically a hydrogel prosthesis for nucleus pulposus
replacement and an acrylic bone cement for the augmentation of vertebral
compression fractures.
Nucleus pulposus replacement
When developing suitable replacements for parts of the human body, it
becomes  clear  how  hard  it  is  to  approach  Nature’s  design.  Million  years  of
evolution have produced complex and perfectly working organs, in complete
synergy. This is also true for the nucleus pulposus. It interacts synergistically
with the annulus fibrosus and the vertebral end-plates. Hence, if the nucleus
needs to be replaced, while the other structures are still functional, it would be
wise to retain them.
The question often posed is why we didn’t develop an injectable nucleus
prosthesis. It would be even more minimally invasive. The main reason is that
an injectable synthetic nucleus can also extrude through an annulus defect [2].
To counter that, the injected nucleus would have to solidify in situ (e.g.  by
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polymerization of thermoreversible gelation) to make it more solid (but not too
stiff). In our situation, this would mean that the injected mixture would have to
contain monomers, which are very toxic substances in general. Hence it is not
surprising that the most successful nucleus replacement to date, the PDN [3], is
no injectable nucleus, but a pre-cured hydrogel.
Building on pioneering work of the PDN, we developed our own nucleus
prosthesis from scratch. In our view, the PDN has two main drawbacks, which
we wanted to address, being insufficient radiopacity (only markers) and an
unnatural implant shape.
At this point we feel we have adequately addressed both drawbacks. The work
so far culminated in the material T94_2, which fulfils the demands as stipulated
in the Introduction to this thesis. In contrast to the PDN, this material is
intrinsically radiopaque at a level that is sufficient for use in the vertebral
column,  and  it  can  be  lathe  cut  to  the  dimensions  of  the  nucleus  cavity
(incorporating its swelling ability). When used clinically, either the material can
be prepared in a range of sizes, and the surgeon can decide on the spot which
size to implant, or the size of the prosthesis can be custom-made, based on T2-
weighted MRI of the nucleus cavity of the patient in question [4].
Still, in the development of this nucleus replacement material, some
compromises  had  to  be  made:  Ideally,  (i)  the  water  content  of  the  implant
would be even higher, approximately 80% (like the natural nucleus). This can
not be realized without doing concessions to the mechanical properties [5] and
radiopacity; (ii) a highly hydrophilic (methacrylic) monomer would be available
with  a  reactivity  ratio  comparable  to  4IEMA,  resulting  in  perfectly  random
copolymers, so no dissolution and consequent mass loss would occur in
aqueous  media.  We  could  find  no  such  monomer,  so  we  had  to  resort  to  an
appropriate chemical crosslinker; and (iii) the hydrogel is loaded with drugs, to
stimulate the natural repair of the annulus. This can be the subject of future
investigation.
Nonetheless, as stated above, we feel we have designed a viable nucleus
prosthesis, featuring intrinsic radiopacity. Unfortunately, the road to actual
clinical use of our nucleus prosthesis is still quite long. For one, fatigue tests
need to be performed, preferably in a confined model, for a large number of
cycles (85 million cycles, equal 40 years of use [6]). All the more since nucleus
replacement is only useful in patients with a healthy (not too degenerated)
annulus fibrosus, which are mainly young patients, meaning the implant has to
function for a long time. To mimic the physiological situation, the loading
protocol  should  be  performed  with  a  diurnal  loading  mode;  for  example  20
hours  of  cyclic  compression  followed  by  4  hours  of  rest  [7].  Also,  animal
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experiments should demonstrate the biofunctionality and –compatibility of the
prosthesis in situ. Interestingly, this prosthesis could also be used to treat back
pain in dogs. Together with experts in veterinary medicine we are exploring this
potential application. At the time of this writing, animal experiments in a rabbit
model are prepared and ready to start. All the necessary approvals are obtained
and nucleus implants are machined and ethylene oxide sterilized. Several
orthopaedic surgeons are willing to perform the implantations. Hopefully these
experiments can start in the near future. After that, the final step before clinical
use of our radiopaque hydrogel, is a clinical pilot study; the new prosthesis is
implanted in selected patients, with written consent, who are monitored for a
certain  amount  of  time.  Fortunately,  already  one  patient  is  available…  the
amateur triathlete who emailed me (Appendix 1).
Acrylic bone cement
The cement we developed for use in vertebroplasty or balloon kyphoplasty, in
contrast to the nucleus prosthesis, was not developed from scratch. Earlier we
prepared an all-polymeric intrinsically radiopaque bone cement for use in
cemented total joint replacements [8]. Only for the present application the
radiopacity had to be increased.
The use of acrylic bone cement, also in contrast to the nucleus prosthesis, does
involve the injection of toxic monomers into the human body. Although we
might  feel  this  is  a  crude  method,  it  is  an  established  technique  with  a  high
success rate.  The question that  remains is  how it  was ever  approved (by the
FDA) in the first place.
Realizing there are no official standards for vertebroplasty cements, the aim of
the study was to design a cement that performs equally to commercially
available BaSO4-containing cement, but that lacks the inorganic radiopacifier
with its inherent deleterious effects.
The iodine-containing cement is still in the development phase and some issues
need to be addressed. The field in which we feel much profit can still be gained
is in the rheological behaviour of the cement after mixing, especially in view of
the  fact  that  for  this  application,  the  cement  needs  to  be  injected  through  a
needle. The viscosity is greatly influenced by the liquid monomer-to-powder
ratio [9], the size (distribution) of the microspheres in the powder [10] and by
the presence of barium sulphate (personal observation). The particle size
distribution of our own microspheres is quite broad and we are currently
working to make it more uniform. We noticed that the presence of barium
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sulphate causes granularity of the cement mixture, another reason to exclude it
from bone cements.
The  greatest  challenge  we  are  faced  with  at  this  point,  is  to  convince  the
conservative medical world to use our all-polymeric cement instead of cements
with  added  radiopaque  agents,  and  to  convince  an  investor  or  company  to
commercialize it.
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1 E-mail from an amateur triathlete with back
pain
Dear Erik
I have today read with much interest your article as mentioned above as I have
suffered degenerative disc disease between Lumbar 5 and Sacrum 1.  Currently
I  am  awaiting  an  MRI  Scan  (within  approximately  the  next  4  months).  The
degenerated disc has been detected by full neck and spine X-rays.
I  am a  teacher  of  Chemistry  at  a  Secondary  School  (children  12-18  years)  in
Perth Scotland, and until two years ago was extremely fit and active - involved
in long distance triathlon races; swim 2.4 km, cycle 180 km and run a marathon
of  42  km  as  a  continuous  race.   No  doubt  this  has  contributed  to  the
degeneration. I am also studying part-time for an MSc in Biological Nuclear
Magnetic Resonance Spectroscopy, so would also have an interest in the
imaging of these gels by MRI scans.
I  am  able  to  understand  the  chemistry  behind  what  you  are  doing  and
desperate  to  regain  my  ability  to  swim,  cycle  and  run.   I  competed  as  an
amateur to a high level in National Championships.  I am only 36 years old.
I appreciate that further testing and trials of the hydrogels are needed before
they become available in routine surgery.  Can you give me an indication as to
when these gels may become available as a cure???
I  am willing  to  offer  myself  as  a  patient  for  use  in  clinical  trials  if  this  would
assist  your  research.   My  mother  and  father-in-law  are  both  Dutch  and
therefore  I  would  have  no  difficulty  in  coming  over  to  The  Netherlands  if
needed.
I look forward to hearing from you.
Regards...........JIM SCANLAN
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2 1H-NMR analysis of the copolymerization of NVP
and 4IEMA
For the determination of the reactivity ratios, we focused on three specific
resonances, i.e. (a) aromatic protons of 4IEMA (either unreacted 4IEMA (? 7.9
ppm and ? 7.7 ppm), or built-in 4IEMA (broadened signals at ? 7.8 ppm and ?
7.7 ppm)), (b) the vinyl proton of NVP (four line pattern at ? 7.0 ppm), (c) the
vinyl  protons  of  4IEMA  (singlets  at  ? 6.0  ppm  and  ? 5.6  ppm).  Figure  2
(Chapter 2) shows these resonances in detail, for f4IEMA =  0.43,  at  0%
conversion (Figure 2A) and at a conversion of 15% (Figure 2B). Integration of
the patterns a, b and c provided detailed information about the conversion and
about the composition of the copolymer formed at the time of the acquisition.
The 1H-NMR spectra were analyzed in two ways: determination of the ratio
consumed NVP : consumed 4IEMA at conversion in the range (i) 4-6% and (ii)
13-16%. At low conversion (i), the composition drift can be neglected. At high
conversion (ii), it is possible to measure the consumption of NVP with higher
accuracy. It was uncertain a priori which  of  the  two  approaches  would  yield
more reliable results in terms of reactivity ratios r4IEMA and rNVP for this particular
reaction.
To make a proper comparison between the different spectra in time, it was
assumed that the combined integral of the four aromatic hydrogen signals
remains constant during the reaction (int. a = int.(a1+a2+a1’+a2’) = 4),  while
the integrals of signals b and c decrease  as  NVP  and  4IEMA  are  built  in  the
growing copolymer chains. From this decrease, the incorporation of monomer in
the polymer chain,  i.e.  the copolymer composition,  is  deduced.  At  time t, the
conversion was calculated using equation 1:
( ) ( )
( ) 0
0
intint
intintintint
100
=
=
+
+-+
´=
t
tt
c..b
c..bc..b
 (%)conversion (1)
In which c  is the average of c1 and c2.
At this conversion, the fraction of built-in 4IEMA is obtained using equation 2:
( ) ( )tt
tt
IEMA
c..bc..b
c.c.F
intintintint
intint
0
0
4
+-+
-
=
=
= (2)
128 | Chapter 7
From the copolymer composition and the monomer feed composition, the
reactivity ratios can be calculated according to equation 3 [1, 2].
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Where F4IEMA  is the molar fraction of 4IEMA in the copolymer and fNVP and f4IEMA
are the molar fractions of NVP and 4IEMA, respectively, in the feed. r4IEMA and
rNVP are the reactivity ratios.
When plotting the left-hand side of the equation against the coefficient of r4IEMA,
r4IEMA and rNVP can be determined, by drawing a linear trendline through the
data points.
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Summary
Back  pain  is  a  major  problem  in  society,  and  the  costs  related  to  it  are
enormous. Disc problems and compression fractures are among the most
common  ailments  to  the  back.  With  our  present  knowledge  on  radiopaque
polymers,  we  hoped  to  contribute  to  the  field  of  spinal  surgery,  by  providing
orthopaedic surgeons with intrinsically radiopaque biomaterials. Intrinsic
radiopacity is essential for completely visualizing an implanted biomaterial. The
basis for rendering our biomaterials radiopaque lies with the monomer 4IEMA,
which contains covalently bound iodine. This monomer can be copolymerized
with other monomers, depending on the desired application.
Chapter  2 deals with a first investigation towards radiopaque hydrogels for
nucleus pulposus replacement. Ideally a nucleus replacement mimics the
functions and behaviour of the natural nucleus. In an attempt to create
radiopaque hydrogels, the iodine-containing monomer 4IEMA was
copolymerized with either one of the hydrophilic monomers NVP and HEMA in
different ratios. The copolymerization reaction of NVP + 4IEMA was studied in
detail using 1H-NMR. It  was found that  4IEMA is  far  more reactive than NVP.
For the nucleus prosthesis eight different copolymers were synthesized with 5 –
20 mol% 4IEMA. These copolymers could be swollen in aqueous media to yield
hydrogels. The resulting hydrogels were investigated for their water content,
cytotoxicity, X-ray opacity, stiffness, rheological properties and hysteresis.
The reactivity ratios of NVP and 4IEMA clarified the polymerization dynamics
and explained the mass loss  of  the NVP-based hydrogels  in  water.  This  mass
loss  is  due  to  the  dissolution  of  NVP  oligomers.  It  was  also  found  that  the
incorporation  of  4IEMA  has  a  significant  effect  on  the  water  content  of  the
hydrogels, but not on the cytotoxicity; all hydrogels were non-cytotoxic. The X-
ray opacity of all swollen copolymers was sufficient for visualizing them in
between two vertebrae. The hydrogels with the highest water content came
closest to the natural nucleus pulposus in terms of rheological behaviour. The
hydrogels containing 5 mol% 4IEMA were in range of the desired stiffness, the
others were too stiff for the intended application. All hydrogels displayed
hysteresis when subjected to cyclic loading, as does the natural nucleus. From
this study we concluded that approximately 5 mol% 4IEMA in combination with
either NVP or HEMA results in promising biocompatible, radiopaque hydrogels
for replacing the nucleus pulposus.
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Consequently, in Chapter 3 we continued the investigation of the radiopaque
hydrogels. This time the focus was on biocompatibility in vivo, implantability
and visualization using X-rays. Copolymers were prepared with 6 mol% 4IEMA
and 94 mol% of either NVP or HEMA, indicated by N94 and H94 respectively.
The stiffness and swelling of both materials was studied and small discs were
implanted in mice. A prototype nucleus prosthesis was lathe cut from N94 and
implanted in  a  lumbar disc  of  a  porcine cadaver.  The porcine spine was then
visualized  using  CT  and  MRI.  This  study  demonstrated  the  feasibility  of  our
approach, the biocompatibility of the materials and the excellent visibility of the
prototype prosthesis in situ using either CT or MRI.
Realizing that  both N94 and H94 still  have their  shortcomings,  being oligomer
dissolution and low swelling capacity respectively, we fine-tuned these materials
as described in Chapter 4. To overcome the dissolution of NVP-oligomers from
N94, a chemical crosslinker was introduced. Also, NVP, HEMA and 4IEMA were
combined  in  a  new  terpolymer,  in  an  attempt  to  combine  the  high  water
content of NVP-based hydrogels with the elasticity of the HEMA-based
materials. This new terpolymer was also chemically crosslinked. The new
crosslinked materials were evaluated and compared to N94 and H94 for an
array of relevant properties. The mass loss was significantly reduced for the
crosslinked materials and they also seemed to perform better mechanically.
Only  the  water  content  was  somewhat  lower  than  N94.  A  preliminary  fatigue
experiment on the new materials suggested fatigue resistance.
Especially  the  terpolymer  has  great  potential  to  serve  as  a  functional  nucleus
prosthesis and it will be evaluated in vivo in a suitable animal model in the near
future.
In Chapter  5 a  switch  has  been  made  from  the  radiopaque  hydrogel  to  a
highly radiopaque cement for the treatment of osteoporotic vertebral
compression fractures. This chapter describes the comparison of 2 highly
radiopaque cements for use in vertebroplasty or kyphoplasty. One cement was
made radiopaque by the incorporation of iodine-containing copolymer in the
powder phase of the cement (IO cement). In the other cement, radiopacity was
introduced  by  the  addition  of  barium  sulphate  (BA  cement),  as  is  commonly
done in clinical practice. Because the addition of high levels of barium sulphate
has raised concerns in the orthopaedic community, the all-polymeric IO cement
was developed and compared to BA cement. Both cements were tested for a
wide array of relevant properties. For a majority of these properties, the
difference between these cements was not significant. Therefore we believe
that IO cement is a viable alternative to BA cement for use in vertebroplasty
and kyphoplasty.
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Samenvatting
Rugpijn is een groot probleem in de samenleving, en de kosten die ermee
gepaard gaan, zijn enorm. Problemen met een tussenwervelschijf en
compressiefracturen behoren tot de meest voorkomende rugaandoeningen. Met
onze huidige kennis van röntgenzichtbare polymeren hoopten we te kunnen
bijdragen aan de wervelkolomchirurgie, door orthopedisch chirurgen te voorzien
van intrinsiek röntgenzichtbare biomaterialen. Intrinsieke röntgenzichtbaarheid
is essentieel voor het compleet in beeld brengen van een geïmplanteerd
biomateriaal. De basis voor het röntgenzichtbaar maken van onze biomaterialen
ligt bij het monomeer 4IEMA, dat covalent gebonden jood bevat. Dit monomeer
kan copolymeriseren met andere monomeren, afhankelijk van de gewenste
toepassing.
Hoofdstuk 2 behandelt een eerste studie naar röntgenzichtbare hydrogelen
om de nucleus pulposus te vervangen. Idealiter bootst een vervanging van de
nucleus, de functies en het gedrag van een natuurlijke nucleus na. In een
poging röntgenzichtbare hydrogelen te maken, is het jood-houdende monomeer
4IEMA gecopolymeriseerd met een van de hydrofiele monomeren NVP en
HEMA, in verschillende ratio’s. De copolymerisatie-reactie van NVP + 4IEMA is
in detail bestudeerd met 1H-NMR. Hieruit bleek dat 4IEMA veel reactiever is dan
NVP. Voor de nucleus prothese zijn acht verschillende copolymeren gemaakt
met  5  –  20  mol%  4IEMA.  Deze  copolymeren  konden  zwellen  in  waterige
oplossingen tot hydrogelen. Deze hydrogelen zijn onderzocht op hun
waterpercentage, cytotoxiciteit, röntgenzichtbaarheid, stijfheid, reologische
eigenschappen en hysterese.
De reactiviteitsratio’s van NVP en 4IEMA helderden de polymerisatie-dynamica
op en verklaarden het massaverlies van de NVP-hydrogelen in water. Dit
massaverlies is het gevolg van het oplossen van NVP-oligomeren. Tevens bleek
dat het toevoegen van 4IEMA een significant effect had op het waterpercentage
van de hydrogelen, maar niet op de cytotoxiciteit; geen van de hydrogelen was
toxisch. De röntgenzichtbaarheid van alle gezwollen copolymeren was
voldoende om ze in beeld te brengen tussen twee wervels. De hydrogelen met
het hoogste waterpercentage leken reologisch het meest op de natuurlijke
nucleus pulposus. De hydrogelen met 5 mol% 4IEMA zaten in het gebied van
de gewenste stijfheid, de overigen waren te stijf voor de bedoelde toepassing.
Alle hydrogelen vertoonden hysterese, net als de natuurlijke nucleus. Uit deze
studie concludeerden wij dat ongeveer 5 mol% 4IEMA, samen met NVP of
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HEMA, resulteert in veelbelovende, biocompatibele, röntgenzichtbare
hydrogelen voor het vervangen van de nucleus pulposus.
Vervolgens zijn we in Hoofdstuk 3 verder gegaan met het bestuderen van de
röntgenzichtbare hydrogelen. Dit keer lag de focus op biocompatibiliteit in vivo,
implanteerbaarheid en röntgenzichtbaarheid. Hiervoor werden copolymeren
gemaakt  met  6  mol%  4IEMA  en  94  mol%  NVP  of  HEMA,  aangeduid
respectievelijk als N94 en H94. De stijfheid en het zwellen van beide materialen
is bestudeerd en kleine schijfjes zijn geïmplanteerd in muizen. Een prototype
nucleus prothese van N94 werd gemaakt op de draaibank en geïmplanteerd in
een lumbale tussenwervelschijf van een varkenskadaver. De wervelkolom werd
vervolgens in beeld gebracht met CT en MRI. Deze studie toonde de
uitvoerbaarheid van onze benadering, de biocompatibiliteit van de materialen
en de uitstekende zichtbaarheid van ons prototype in situ met zowel CT als
MRI.
Omdat we ons realiseerden dat zowel N94 als H94 nog steeds tekortkomingen
hebben, zijnde respectievelijk massaverlies en lage zwelcapaciteit, hebben we
deze materialen verder geoptimaliseerd, zoals beschreven in Hoofdstuk 4. Om
het oplossen van oligomeren uit N94 te voorkomen, werd een chemische
crosslinker geïntroduceerd. Tevens zijn NVP, HEMA en 4IEMA gecombineerd in
een nieuw terpolymeer, in een poging het hoge waterpercentage van de NVP-
hydrogelen te combineren met de elasticiteit van de HEMA-hydrogelen. Dit
nieuwe terpolymeer is ook gecrosslinkt. De nieuwe gecrosslinkte materialen zijn
getest op een aantal relevante eigenschappen en vergeleken met N94 en H94.
Het massaverlies was aanzienlijk verminderd bij de gecrosslinkte materialen en
ze leken mechanisch ook beter te voldoen. Enkel het waterpercentage was iets
lager dan N94. Een voorlopig vermoeiingsexperiment leek te duiden op
vermoeiingsweerstand.
Voornamelijk het terpolymeer is veelbelovend als functionele nucleus prothese,
en  dit  zal  in  de  nabije  toekomst in vivo worden getest in een geschikt
diermodel.
In Hoofdstuk 5 maken we een omschakeling naar een extra röntgenzichtbaar
cement ter behandeling van osteoporotische compressiefracturen in de wervels.
Dit hoofdstuk beschrijft de vergelijking van twee extra röntgenzichtbare
cementen voor gebruik in vertebroplastie of kyphoplastie. Een cement is
röntgenzichtbaar gemaakt door toevoeging van een jood-houdend copolymeer
in het poeder van het cement (IO cement), het andere is röntgenzichtbaar
gemaakt door bariumsulfaat toe te voegen (BA cement), zoals gewoonlijk
gedaan wordt in de kliniek. Omdat in de orthopedische wereld ongerustheid
bestaat over de toevoeging van grote hoeveelheden bariumsulfaat, werd het
136 | Chapter 8
volledig-polymere IO cement ontwikkeld en vergeleken met BA cement. Beide
cementen zijn getest op een aantal relevante eigenschappen. Voor de meeste
hiervan was het verschil tussen de cementen niet significant. Daarom denken
wij dat IO cement een goed alternatief is voor BA cement in vertebroplastie en
kyphoplastie.
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